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ABSTRACT 
 
UTILIZATION OF EMULSION CHEMISTRIES FOR DELIVERY AND ANTIVIRAL 
APPLICATION OF CARVACROL 
FEBUARY 2020 
HAO-YUAN HSU, B.S., ASIA UNIVERSITY, TAIWAN 
M.S., UNIVERSITY OF MASSACHUSETTS, AMHERST 
Directed by: Professor Matthew D. Moore 
Human norovirus (HuNoVs) are the most common enteric pathogen around the world that 
cause ~50% of foodborne illness of disease outbreaks annually. HuNoVs are the member of 
the Caliciviridae family, which consist of small (38 nm), unenveloped, single stranded RNA 
(ssRNA) viruses. Norovirus are divided into 5 genogroup (GI, GII, GIII, GIV, GV, GVI and 
GVII). The GI, GII, and GIV cause human illness, in addition, GII.4 genotype cause the 
most human disease. Due to HuNoVs are difficult cultured in vitro, the cultivable HuNoVs 
surrogates have been widely studied. Recently, some studies have been conducted with 
HuNoVs surrogates, for example bacteriophage MS2. MS2 is conservative surrogate for 
nonenveloped viruses which there is a close relationship to the behavior of HuNoVs, thus 
we can examine the infection control measures for HuNoVs. Despite plenty of treatment 
method been done on testing antiviral effect on bacteriophage MS2, for example UV 
inactivation, steam ultrasound and antimicrobial etc., plant-based nanoemulsion treatment 
has yet to be explored. Carvacrol is a major component of oregano essential oil and is 
responsible for their antimicrobial activity on the growth of various microorganism. In this 
study, carvacrol nanoemulsions were formed by using the spontaneous emulsification for 
vi 
 
testing the nanoemulsion stability (14 days shelf life study on its droplet size and particle 
charge) and antimicrobial activity.  
 
In carvacrol nanoemulsion 14 days shelf life test, the droplet size and particle charge stay 
stable at three different treatment environments (4°C, 20°C and 37°C). The results proved 
that nanoemulsion (was formed with surfactant agents and medium-chain triglycerides) is 
stable system that gives consistent droplet size and charge. Although, the low antimicrobial 
activity was investigated at carvacrol nanoemulsion, the strong antimicrobial effects have 
been found when carvacrol or carvacrol combined with ionic surfactant of treatment on MS2 
and Escherichia coli. Taken together, in the wake of growing consumer demand for different 
“natural” products in a number of industries, our study broadly informs the development and 
study of functionalized carvacrol active compound that can not only provide beneficial 
health for human but can also examine antimicrobial efficacy of control measures for public 
health. 
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CHAPTER 1  
REVIEW: DEVELOPMENTS IN INACTIVATION OF INFECTIOUS HUMAN 
NOROVIRUSES 
1.1. Introduction 
HuNoVs are the most common cause of epidemic and sporadic acute gastroenteritis around 
the world which are belong to the member of the Caliciviridae family. Noroviruses (NoVs) 
consist of small, 38 nm, nonenveloped single stranded RNA (ssRNA) viruses they are 
divided into 5 genogroups (GI, GII, GIII, GIV, GV, GVI and GVII); of which genogroups 
I, II and IV cause human illness. The genotypes are further divided from genogroup, and 
GII.4 causing the most HuNoVs disease (Moore et al., 2015). HuNoVs have a low infectious 
dose, as few as 18 viral particles, and it can be spread through fecal-oral-transmission, 
deposition on surfaces, and through airborne droplets of vomitus. Furthermore, HuNoVs 
can be easily spread through consumption of food, water and environmentally after 
deposition on surfaces. Therefore, identification and use of effective HuNoVs inactivation 
agents are crucially researched.  
 
Although, in vitro cultivation techniques for HuNoVs have been reported (Ettayebi et al., 
2016; Jones et al., 2014), these still difficult for utilizing on the study of HuNoVs 
inactivation. Therefore, reverse transcriptase quantitative polymerase chain reaction (RT-
qPCR) is commonly used to quantify HuNoVs inactivation. However, viral reduction of 
RT-qPCR signal does not completely correspond to viral infectivity. Although, some 
techniques (porcine gastric mucin (PGM) binding assay) have been developed for use in 
conjunction with RT-qPCR (Manuel et al., 2018), the technique still cannot completely 
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present the entire RNA sequence for RT-qPCR. This is due to the fact that infectious or 
damaged protein may still attach with RT-qPCR when detect the antiviral effect. In addition 
to RT-qPCR, HuNoVs inactivation is also considered by using the close relationship of 
cultivable surrogate viruses; however, these surrogates have potential limitations in their 
translation to HuNoVs inactivation (Richards, 2012). Using these methods and treatments, 
numerous antimicrobial agents have been investigated; however, the identification of 
effective agents that are not consider for food grade supply. Additionally, numerous 
advances and investigation of HuNoVs inactivation agents have been reported in recent 
years. The purpose of this review is to present recent studies on HuNoVs inactivation that 
specifically by utilizing HuNoVs.  
1.2. Human Norovirus Inactivation on Hands, Finger Pads or With Hand Sanitizer 
The efficiency of handwashing with soap and water containing sterillium propan-1-ol 30% 
and mecetroniumetil sulfate sterillium, Viruguard hand disinfectants and Unicura hand soap 
were tested against NoVs GI.4 and GII.4 using finger pad tests (Tuladhar et al., 2015). The 
finger pads were contaminated with virus and dried before being applied to the treatments. 
Washing with soap and water removed genomic copies of noroviruses GI.4 (>6 log10), and 
GII.4 (4 log10) completely from all finger pads. Treating hands with propanol-based hand 
disinfectant showed low or no reduction to complete reduction with mean genomic copy 
reduction of NoVs GI.4 (>2.6 log10) and GII.4 (>3.3 log10) showed in Table 1.   
 
In a recent study, two alcohol-based hand washes, quaternary ammonium compounds and 
chlorine dioxide were all ineffective at promoting virolysis of human norovirus (Nowak et 
al., 2011). However, it was found that NoVs GII.4 were sensitive (99.92% RNA digested) 
to a combination of heat and alkali condition (0.1M NaOH at 50◦C) (Table 1). The authors 
examined the persistence of the NoV GII.4 by RT-qPCR for the amplification, for detecting 
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on inactivation effect. 
 
Another study presented in 2010 has tested the effectiveness of sodium hypochlorite and 
ethanol (Liu et al., 2010) at different concentrations. The antibacterial hand sanitizer were 
observed for the inactivation of norovirus on finger pads. It was found that sodium 
hypochlorite has strong inactivation between 160 ppm and 1600 ppm after an exposure of 
30s, a 5 log10 reduction was observed at sodium hypochlorite concentrations of 160 and 
1,600 ppm on GI.1 (Table 1). At ethanol test, 3, 17, 31, 47, 62, and 95% concentrations were 
low antiviral efficacy (0.5 log10 reduction). Antibacterial liquid soap treatment gave a 
reduction of 0.67 to 1.20 log10 reduction and a water rinse only gave 0.58 to 1.58 log10 
reduction. The alcohol-based hand sanitizer was low inactivation, reducing the norovirus 
genomic copies less than water alone, with only a 0.14 to 0.34 log10 reduction. The treatments 
in this study suggest that ethanol should not be used as an inactivation method. 
 
VIRUS
ES 
INACTIVA
TION 
AGENT 
RANGE OF 
CONCENTRA
TIONS OR 
TREATMENT
TIME 
QUANTIFICA
TION 
METHOD 
RANGE 
OF 
REDUCTI
ONS 
REFERE
NCE 
GI.4, 
GII.4 
Washing with 
soap and 
water 
30 s Real-time PCR GI.4:>6 
log10, GII.4: 
4 log10 
(Tuladhar 
et al., 
2015) 
GI.4 
GII.4 
Propanol-
based hand 
disinfectant 
30min PCR units 
(PCRU)/mL 
GI.4: >2.6 
log10 
GII.4: 3.3 
log10 
(Tuladhar 
et al., 
2015) 
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Table 1. Inactivation of HuNoVs on hands, finger pads or with hand sanitizer 
 
1.3. Human Norovirus Inactivation on Hard Surfaces 
For a study conducted in 2017, the authors applied 7.5% hydrogen peroxide and a 0.2% 
chlorine dioxide-surfactant-based product using a fogging delivery system against NoVs 
GI.6 and GII.4 (Montazeri et al., 2017). At 12.4 ml/m3 hydrogen peroxide, disinfectant 
achieved a 2.5 ± 0.1 and 2.7 ± 0.3 log10 reduction in NoV GI.6 and GII.4 genome copies 
within 5 min (Table 2). At the same disinfectant formulation concentration, 12.4 ml/m3 
chlorine dioxide-surfactant-based product resulted in 1.7 ± 0.2 and 0.6 log10 reduction in 
GI.6 and GII.4 within 10 min. However, increasing the disinfectant formulation 
concentration to 15.9 ml/m3 negatively impacted its efficacy.  
 
GII.4 NaOH 0.1M at 50◦C RT-qPCR 
 
99.92% 
RNA 
digested 
(Nowak et 
al., 2011) 
GI.1 Sodium 
hypochlorite  
160 and 
1600ppm for 30 s 
Suspension 
assay 
5 log10 (Liu et al., 
2010) 
GI.1 
 
Ethanol All concentration 
for 30s 
Suspension 
assay 
0.5 log10 (Liu et al., 
2010) 
GI.1 
 
Antibacterial 
liquid soap 
30s RT-PCR 0.67 to 1.20 
log10 
(Liu et al., 
2010) 
GI.1 Water rinse 30s American 
Society for 
Testing and 
Materials 
(ASTM) 
0.58 to 1.58 
log10 
(Liu et al., 
2010) 
GI.1 
 
Alcohol-
based 
handwash 
Containing 62% 
ethyl alcohol for 
30s 
ASTM 0.14 to 0.34 
log10 
(Liu et al., 
2010) 
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The efficiency (Table 2) of neutral electrolyzed water (NEW) was observed for the 
inactivation of GII.4 in suspension on stainless steel surfaces with and without an additional 
soil load (Norovirus et al., 2017). The degradation norovirus VP1 major capsid protein at 
250 ppm around 5min, and increased virus particle aggregation at 150 ppm after 30min. 
Only the 250 ppm NEW concentration, without soil load, produced greater than a 5.4 log10 
reduction in NoVs genome copy number. The contact time on surfaces to 5, 10 and 15 min 
reduced HuNoVs genomic copies by 0.5, 1.6 and 2.4 log10. Moreover, NEW at 250 ppm 
free available chlorine produced a 4.8 and 0.4 log10 reduction in norovirus genome copy 
number after 1 min in suspension and on stainless steel.  
 
A blend of silver ions and citric acid (SDC) had an effect on HuNoVs GI.6 and GII.4 
(Manuel et al., 2017). The suspension assays showed a 4 log10 reduction in RNA copy 
number within 5 min for both GI.6 and GII.4, along with a 2–3 log10 reduction in 30min 
(Table 2). The results showed no further additional log10 reduction when extend over than 
5min. When incorporating a simulated soil load into the sample matrix significantly reduced 
formulation efficacy, ~2.5 log10 was achieved on both GI.6 and GII.4. 
 
Fecal suspensions for a HuNoVs GII.4 or virus-like particles (VLPs) were exposed to 
copper alloys or stainless steel for 0, 60, 120, and 240min in a study conducted in 2015 
(Manuel et al., 2015). When using RT-qPCR assays on stainless-steel, there was a 1.1 log10 
reduction in RNA copy number after a time of 240min (Table 2). When exposed for 60 min, 
a 2–3 log10 reduction in RNA copy number was observed for surfaces containing 70% 
copper. The research also showed further evidence that although there was damage to the 
NoVs GII.4 capsid, HuNoVs remained stable on stainless steel surfaces for up to 240 min. 
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For a study in 2014, the authors applied different concentration of ethanol solutions, 70% 
and 90%, to test the reductions of NoVs GI.1, GI.5, GI.5 semi purified (SP) preparations, 
GII.13, and GII.13 SP preparations RNA levels after 1 min of exposure (Cromeans et al., 
2014). The GI.1 RNA was reduced by as much as 1.1 log10 units on 90% of ethanol 
concentration, however, 70% was reduced by less than 1 log10 unit. The GI.5 SP RNA level 
was reduced by as much as 3.5 log10 units on both 70% and 90 % of ethanol concentration 
(Table 2). And GI.5 reach 2.0 log10 unit of reduction on 90% of ethanol concentration, 
whereas the GII.13 and GII.13 SP RNA levels were reduced <1 log10 unit. In the same 
article, the viruses were dried on stainless steel with fifty microliters of a chlorine solution 
at concentrations of 200 ppm or 1,000 ppm. Each was added to the virus for 5min. The GI.5 
SP RNA level was reduced by <1 log10 unit after treatment with both 200 and 1,000 ppm 
chlorine. The GII.13 SP RNA level was reduced by <0.5 log10 unit at concentrations of 200 
ppm or 1,000 ppm. 
 
The qualities of HuNoVs attached to stainless steel disks was also observed in an article 
published in 2010. (Girard et al., 2010). The paper wanted to observe a technique for 
disinfecting NoVs using household disinfectants. The attachment of HuNoVs and murine 
norovirus (MNV) to stainless steel disks was tested against a range of pH and relative 
humidity (RH). The maximum attachment of 103 PFU was obtained after a contact time of 
10 min. Interestingly, extending the contact time to 60 or 120min did not increase viral. A 
decrease in titer was more significant at low RH. When using household items for chemical 
treatments, sodium hypochlorite showed inactivation exceeding 3 log10 reduction for 
HuNoVs after a contact time of 10min (Table 2); however, only a 2 log10 reduction was 
obtained after 5 min. The study suggests that MNV was more sensitive than HuNoVs to 
chemical disinfectants. In the evaluation of disinfection efficacy, only sodium hypochlorite 
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was effective against NoVs.  
 
VIRUS
ES 
INACTIVA
TION 
AGENT 
RANGE OF 
CONCENTRA
TIONS OR 
TREATMENT
TIME 
QUANTIFICA
TION 
METHOD 
RANGE 
OF 
REDUCTI
ONS 
REFERE
NCE 
GI.6 
GII.4 
Hydrogen 
peroxide on 
Stainless steel  
5 min at 12.4 
ml/m3 
RT-qPCR, GI.6: 2.5 ± 
0.1 log10 
GII.4: 2.7 ± 
0.3 log10 
(Montazeri 
et al., 
2017) 
GI.4 
GII.4 
Chlorine 
dioxide on 
stainless steel 
embossing 
10 min at 12.4 
ml/m3 
RT-qPCR, GI.6: 1.7 ± 
0.2 log10 
GII.4: 0.6 
log10 
(Montazeri 
et al., 
2017) 
GII.4 NEW 
on stainless 
steel 
250 ppm after 1, 
5, 10, 15, and 30 
min 
RT-qPCR 
 
0.4, 0.5, 
1.6, 2.4, and 
5.0 log10 
(Norovirus 
et al., 
2017) 
GII.4 NEW 160 
and 1600ppm 
on stainless 
steel 
At 250 ppm free 
available 
chlorine for 1min 
Suspension 
assay 
4.8 log10 on 
suspension 
0.4 log10 on 
stainless 
steel 
(Norovirus 
et al., 
2017) 
GI.6 
GII.4 
SDCon 
stainless steel 
surfaces. 
5 min 
30 min 
Suspension 
assay 
4.0 log10 
and 
2.0 to 3.0 
log10 
(Manuel et 
al., 2017) 
GII.4 
VLPs 
Stainless steel 
alloys 
contained 
>70% copper 
60 min 
240min 
RT-qPCR 2 to 3 log10 
1.1 log10 
(Manuel et 
al., 2015) 
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Table 2. Inactivation of HuNoVs on hard surface 
 
1.4. Human Norovirus Inactivation in Solution  
 In 2017, peracetic acid (PAA) and monochloramine in both wastewater (WW) and 
phosphate buffer (PB) were tested for their ability to inactive HuNoVs GI and GII (Dunkin 
et al., 2017). A 3.3 log10 reductions of GI was found when treated with 15 mg/l at a dose 
of monochloramine after 120 min with enzymatic pretreatment (EPT) (Table 3). At a high 
dose of 10 mg/l PAA predicted reductions of GI were 3.3 with EPT. In PB, 
monochloramine and PAA exhibited similar effectiveness against GI and GII, both 
disinfectants were able to achieve approximately 3 log10 reduction. In WW, 
GI.1 
 
90% of 
ethanol 
1 min of 
exposure 
RT-qPCR 1.1 log10 (Cromeans 
et al., 
2014) 
GI.5, 
GII.13 
and 
GII.13 
SP 
90% of 
ethanol on 
stainless steel 
1 min of 
exposure 
RT-qPCR GI.5: 2 
log10 
GII.13 and 
GII.13 SP: 
<1 log10 
(Cromeans 
et al., 
2014) 
GI.5 SP 70 and 90% 
of ethanol on 
stainless steel 
 
1 min of 
exposure 
RT-qPCR 3.5 log10 (Cromeans 
et al., 
2014) 
GI.5 SP 
GII.13 
SP 
Chlorine 
solution on 
stainless steel 
200 ppm or 
1,000 ppm for 5 
min 
RT-qPCR GI.5 SP: 
<1 log10 
GII.13 SP: 
<0.5 log10 
(Cromeans 
et al., 
2014) 
 
NoVs Sodium 
hypochlorite 
on stainless 
steel 
5 and 
10 min 
RT-PCR and 
plaque assay 
5min: 2 
log10 
10min: 3 
log10 
(GIRARD 
et al., 
2010) 
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monochloramine and PAA were more effective in treating GI. Monochloramine was able 
to achieve ~ 2 log10 reduction of GI, while PAA has only achieved less than 1 log10 
reduction. However, GII in WW as for both disinfectants were unable to achieve even 0.5 
log10 reduction. 
 
 One in 2016 looked at ethanol, sodium hypochlorite, hydrogen peroxide, quaternary 
ammonium compounds, and iodine using an anti NoV GII.4 monoclonal antibody 
conjugated immunomagnetic separation (IMS) combined with qRT-PCR (Ha et al., 2016). 
Ethanol was diluted between 10%-70% and had no disinfection effect against GII.4 as 
shown by the less than 1 log10 reduction (Table 3). Sodium hypochlorite at 200, 500, and 
1000 ppm resulted in mean log10 reductions of 1.55, 1.85, and 2.45 (Table 3); however, 
50 and 100 ppm sodium hypochlorite shown by the log10 reductions of less than 1. Alkyl 
dimethyl benzyl ammonium chloride (40%), containing quaternary ammonium of 
treatments at 200, 1,000, and 2000 ppm achieved log10 reductions of 0.06 ± 0.12, 0.19 ± 
0.13, and 0.58 ± 0.33 In this study, 200 and 1000 ppm quaternary ammonium compounds 
had almost no effect, and 2000 ppm demonstrated a mean log10 reduction of less than 1 
after 10 min of contact. Iodine (99.99% trace metal basis) was diluted with deionized 
sterile water to 25, 100, 250, and 500 ppm. A 0.30 ± 0.05, 0.41 ± 0.06, 0.57 ± 0.14, and 
0.71 ± 0.13 log10 reduced of NoV GII.4 was found. 
 
One study (Koromyslova et al., 2015) found that NoVs that authors treated VLPs with 
different concentrations of citrate buffer. Between 0.49 and 7.85 mM of citrate buffer, the 
VLPs appeared no effect compared with untreated VLPs. However, at 15.63 mM, a small 
number of the VLPs had slightly altered morphology, i.e., the outer spikes of the VLPs 
were surrounded by a new ring-like structure. Where at 62.50 mM of citrate buffer the 
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majority of VLPs showed the ring-like structure. The diameters of the VLPs were 
manually measured at 0, 0.95, 7.81, 62.50, and 125 mM of citrate buffer shown in Table 
3. At 0, 1, and 7.81 mM of citrate buffer, the diameter of the VLPs were 42 to 44 nm, 
while at 62.50 and 125 mM of citrate buffer, the diameter of the VLPs were 46 to 49 nm. 
 
In another study, it was found that antiviral activity on NoVs were generally < 0.5 log10 
reduction for both GII.2 and GII.4 when using 50, 70, and 90% ethanol solutions tested at 
(Grace et al., 2013). The disinfection efficacy for sodium hypochlorite, authors tested at 
concentrations of 5, 75, 250, 500, and 1,000 ppm. The results showed no significant 
inactivation at < 1,000 ppm on GII.2 strain. However, for the GII.4, efficacy was only 
observed at the highest concentration tested, 1,000 ppm, there was a strong antiviral (4.5 
log10) reduction in viral genome copy number (Table 3). The quaternary ammonium 
compound blend were ineffective at inactivating both strains, with < 0.5 log reductions at 
all concentrations on GII.2 and GII.4. 
 
Different concentrations of 50%, 70%, 90%, of ethanol and isopropanol were tested for 
inactivation in an article published by Park in 2016 (Park et al., 2016). NoVs positive stool 
specimens (14 GI and 16 GII) and three stool samples of GI.1 (from human volunteers) 
were suspended in ethanol and isopropanol. The result showed that exposure to 70% and 
90% ethanol reduced viral RNA titers of 9 and 13 of the 14 GI strains by > 1.8 log10 
reduction shown in Table 3. The titers of 4 (3 GI.6 and 1 GI.7) of the GI strains were > 
1.8 log10 reduction after exposure to 90% isopropanol, whereas no RNA reduction was 
observed for 50% ethanol, or for 50% and 70% isopropanol. Exposure to 90% alcohols 
achieved 0.9 log10 reduction of all 9 GII.4 strains. Overall, exposure to 70% and 90% 
ethanol and 90% isopropanol resulted with an average of 1.2 ± 1.1, 1.4 ± 0.9, and 1.0 ± 
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0.8 log10 reduction on RAN copies. After exposure to 50% and 70% ethanol, RNA titers 
of GII.4 Den Haag and GII.4 Sydney viruses were showed >1.9 log10 reduction whereas 
the titers for GII.4 New Orleans viruses were reduced by less than 0.5 log10 reduction. 
After exposure to 50% isopropanol, RNA titers of both GII.4 Den Haag viruses and 3 of 
the 4 GII.4 Sydney viruses were achieved > 1.0 log10 reduction, while RNA titers of GII.4 
New Orleans were reduced by 0.5 log10 RNA copies/ml. 
 
It  also has been stated that sodium hypochlorite, sodium hydroxide, sodium, ethanol, 
carbonate, potassium carbonate, potassium hydroxide and hydroxide can in active NoVs 
VLPs (Sato et al., 2016). The treatment on VLPs shown no change after 30s and 60s 
exposures to 200 ppm sodium hypochlorite, but were slightly deformed after exposure for 
180s. VLPs were also slightly changed morphologically within 30s of exposure to 50% 
ethanol, but deformation after 60s with 60% ethanol. However, VLPs did not change 
morphologically after 180s of exposure to 12.5 mM carbonate but were slightly deformed 
after exposure to 25 mM for 10s. Deformation of VLPs was more marked after exposure 
to 25mM for 60s. Deformation and aggregation of VLPs were observed after exposure to 
sodium hydroxide and potassium hydroxide under specific conditions (Table 3). There 
were no significant differences between the morphology of particles treated with sodium 
and that of those treated with potassium hydroxide. VLPs were slightly deformed 
morphologically within 180s of exposure to 25mM hydroxide and within 10s of exposure 
to 50mM hydroxide.  
 
Another study looked at the interactions of NoVs GII.4 with available chlorine (Illarruel-
lopez, 2012). The results support the idea that the matrix effects have a significant effect 
on virus survival. GII.4 virolysis was measured using RNase pretreatment and RT-QPCR. 
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The 610ppm available chlorine at 10-13% concentration required to reduce GII.4 >4 log10 
reduction in infectivity (Table 3).   
 
Another study has observed sodium hypochlorite (Liu et al., 2015) at a concentration of 
1600 ppm, produced complete inactivation of GI.1with an average of 4.84 log10 reduction 
and also completely inactivated GII.4 with an average 3.74 log10 reduction in 2min contact 
time. In contrast, 70% ethanol exhibited low antiviral activity, 0.81 and 0.14 log10 
reduction for GI.1 and GII.4. Ammonium chloride exhibited no effect against either 
GI.1or GII.4. The disinfectant Oxivir-TB with 0.5% hydrogen peroxide exhibited 1.11 
and 0.94 log10 reductions against GI.1and GII.4. Lysol with lactic acid, produced 2.29 
log10 reduction in GI.1 and an average log10 reduction in GII.4 of 0.21. Exposure to the 
prototype disinfectant resulted in the greatest reductions of GI.1 (3.19 log10) and o GII.4 
(1.38 log10) (Table 3). 
  
VIRUS
ES  
INACTIVA
TION 
AGENT 
RANGE OF 
CONCENTRA
TIONS OR 
TREATMENT
TIME 
QUANTIFICA
TION 
METHOD 
RANGE OF 
REDUCTI
ONS 
REFERE
NCE 
GI Monochlora
m (15 mg-
min/L) 
120 min with 
enzymatic 
pretreatment 
(EPT) 
RT-qPCR, 3.3log10 (Dunkin et 
al., 2017) 
GI Peracetic acid 
(PAA) 
(10 mg/L) 
120 min with 
EPT 
RT-qPCR, 3.3log10 (Dunkin et 
al., 2017) 
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GI 
GII 
Monochlora
mine and 
PAA 
120 min with 
0.01M PB 
RT-qPCR 
 
3 log10 (Dunkin et 
al., 2017) 
GI 
 
Monochlora
mine and 
PAA 
120 min with 
WW 
RT-qPCR 
 
Monochlora
mine: 2 log10 
PAA: <1 
log10 
(Dunkin et 
al., 2017) 
GII.4 Ethanol 
 
Diluted to 10% 
to 70% 3000 
ppm 
IMS combined 
with qRT-PCR 
<1 log10 (Ha et al., 
2016) 
GII.4 Sodium 
hypochlorite 
200, 500, and 
1000 ppm 
IMS combined 
with qRT-PCR 
1.55, 1.85, 
and 2.45 
log10 
(Ha et al., 
2016) 
 
GII.4 Alkyl 
dimethyl 
benzyl 
ammonium 
chloride 
(40%) 
200, 1,000, and 
2000 ppm 
IMS combined 
with qRT-PCR 
0.06 ± 0.12, 
0.19 ± 0.13, 
and 0.58 ± 
0.33 log10 
(Ha et al., 
2016) 
GII.4 Iodine 
 
25, 100, 250, and 
500 ppm 
IMS combined 
with qRT-PCR 
0.30 ± 0.05, 
0.41 ± 0.06, 
0.57 ± 0.14, 
and 0.71 ± 
0.13 log10 
(Ha et al., 
2016) 
GII.4 Quaternary 
ammonium 
compounds 
2000 ppm IMS combined 
with qRT-PCR 
<1 log10 
 
(Ha et al., 
2016) 
VLPs. Citrate buffer 0, 1, and 7.81 
mM 30 min 
62.50 and 125 
mM 30 min 
Electron 
microscopy and 
ELISA 
VLPs from 
42 to 44 nm 
VLP from 
46 to 49 nm 
morphology 
(Koromysl 
et al., 
2015) 
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GII.2 
GII.4 
Ethanol 
solutions 
50, 70, and 90% RT-qPCR <0.5 log10 (Grace et 
al., 2013) 
GII.4 Sodium 
hypochlorite 
1,000 ppm RT-qPCR 4.5 log10 (Grace et 
al., 2013) 
GII.2 
GII.4 
Quaternary 
ammonium 
compound 
0.1, 1.0, and l0% 
concentrations 
RT-qPCR < 0 .5 log10 (Grace et 
al., 2013) 
GI 
GI.6 
GI.7 
70% and 
90% Ethanol 
and 
90% 
isopropanol 
 RT-qPCR > 1.8 log10 (Park et 
al., 2016). 
GII.4 Ethanol and 
isopropanol 
90% RT-qPCR 0.9 log10 (Park et 
al., 2016). 
GII.4 70% and 
90% Ethanol 
and 
90% 
isopropanol 
 RT-qPCR 70 and 90% 
ethanol:1.2 
and 1.4 log10 
90% 
Isopropanol: 
1.0 ± 0.8 
log10 
(Park et 
al., 2016). 
GII.4 
Den 
Haag 
and 
GII.4 
Sydney 
 
Ethanol 50% and 70% RT-qPCR >1.9 log10 (Park et 
al., 2016). 
VLPs 200 ppm 
sodium 
hypochlorite 
180s TEM Slightly 
deformed 
(Sato et 
al., 2016) 
VLPs 60% ethanol 60s TEM Deformation (Sato et 
al., 2016) 
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Table 3. Inactivation of HuNoVs in solution 
 
1.5. High Pressure Inactivation on Human Norovirus 
High pressure processing (HPP) inactivation is commercial used to process 
VLPs 25mM 
carbonate 
10s. TEM Slightly 
deformed 
(Sato et 
al., 2016) 
VLPs 25mM of 
sodium 
hydroxide 
and 
potassium 
hydroxide 
180s TEM Slightly 
deformed 
(Sato et 
al., 2016) 
GII.4 10-13% 
Chlorine 
610 ppm Plaque assay 
and 
RT-qPCR 
>4 log10 (Illarruel-
lopez et 
al., 2012 
GI.1 
GII.4 
Sodium 
hypochlorite 
1600 ppm 2min IMS /RT-qPCR 4.84 log10 
3.74 log10 
(Liu et al., 
2015) 
GI.1 
GII.4 
ethanol 70% ethanol 
2-10min 
IMS /RT-qPCR 0.81 log10 
0.14 log10 
(Liu et al., 
2015) 
GI.1 
GII.4 
Oxivir-TB 
with 0.5% 
hydrogen 
peroxide 
5min IMS /RT-qPCR GI.1: 1.11 
log10 
GII.4:0.94 
log10 
(Liu et al., 
2015) 
GI.1 
GII.4 
Lysol 
lactic acid 
5min IMS /RT-qPCR GI.1: 2.29 
log10 
GII.4: 0.21 
log10 
(Liu et al., 
2015) 
GI.1 
GII.4 
Prototype 
disinfectant 
using 
4 to10min IMS /RT-qPCR GI.1: 3.19 
log10 
GII.4:1.38 
log 
(Liu et al., 
2015) 
16 
 
various kinds of foods mainly to increase their shelf life and enhance food safety 
by inactivating pathogenic bacteria. It is commercially used as a processing aid; 
for example, it has been used to facilitate oyster shucking. Commercially HPP-
treated foods include those that have been involved in HuNoVs outbreaks, such 
as oysters, salsa, and guacamole (Li et al., 2015). 
 
In a study conducted in 2012, the effectiveness of HPP is observed for its ability 
in disrupting the capsid of VLPs (Lou et al., 2012). Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) was used, and the results 
showed that the integrity of the capsid structure was not disrupted when HuNoV 
VLPs were treated at 500 MPa for up to 30min. After pressurization for more 
than 45 min, the number of 38-nm particles observed was notably reduced shown 
in Table 4, while the 23-nm particles remained unaffected. The pressure was 
increased to 600 MPa at 4°C for 5 to 60 min, the results were essentially similar 
to those at 500 MPa. As the holding time increased to 60 min, the 38-nm VLPs 
disappeared, whereas the 23-nm VLPs were still intact. The pressure level was 
increased to 700 MPa, at 45 min, the 38-nm VLPs were undetectable (Table 4), 
but a considerable number of 23-nm particles were still present. At 800 MPa, the 
number of 38-nm VLPs was notably reduced after 15 min, and the 38-nm 
particles were undetectable after a 30-min treatment. The number of 23-nm 
particles also dramatically decreased after treatment at 800 MPa for 45 min. At 
900 MPa, after a 1-min treatment, the number of 38-nm VLPs was significantly 
reduced, and after 2 min, no intact 38-nm VLPs were detected and the number of 
23-nm VLPs was dramatically reduced 
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In 2011, it was also observed applying a high hydrostatic pressure (HHP) 
treatment can be used to inactive HuNoVs in HPP (Sanchez et al., 2011). 
Different time and pressure conditions were used on each sample, being 200, 300, 
350, 400, 450, and 500 MPa for 15min at initial temperatures of 25°C and 45°C.  
All tested treatments reduced the numbers of HuNoV by < 0.5 log10 reduction as 
determined by RT-qPCR (Table 4); in other words, NoV was detected by RT-
qPCR even after treatments at 500 MPa for 15 min. Similarly, the effect of HPP 
on NoVs in CaCl2 resulted in inactivation no higher than 0.5 log10 reduction 
independently of treatment temperature. 
 
In a more recent study from 2017, high hydrostatic pressure (HHP) was used on 
GII.4 and GI.1 when found on green onions and salsa (Sido et al., 2017). HHP 
inactivation studies were conducted at 100–600 MPa for 2 min at an initial 
temperature of 1°C to determine optimum HHP processing conditions. It was 
desired to achieve a ≥3 log reduction of the strains. To achieve >3 log10 reduction 
of GI.1, HHP treatment should be conducted at 600MPa and 500MPa for green 
onions and salsa respectively. To achieve >3 log reduction of GII.4, HHP 
treatment should be conducted at 500 MPa and 300MPa for green onions and 
salsa respectively. For green onions, HHP treatment could reduce GI.1 by >3.0 
log10 at 600 MPa while >3.87 log reduction was achieved for GII.4 under the 
same condition (Table 4). The HHP treatment of 300 MPa reduced HuNoV GII.4 
by 3.31 log10 reduction in salsa and 2.57 log10 reduction on green onions. Similar 
results were also found with salsa which showed 1.39 log10 reduction of HuNoV 
GI.1 and 3.52 log10 reduction of HuNoV GII.4 at 400 MPa. Food matrices also 
influenced HHP inactivation of GI.1 and GII.4, HuNoV showing higher 
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sensitivity to HHP treatment in salsa than on green onions.  
 
Another group compared the results of HHP inactivation of a GI.1 and GII.4 
strain using different PGM-MB/PCR (Li et al., 2015). HuNoV GII.4 and GI.1 
were pressurized at 150 to 550, 50 to 400, 250 to 575, and 100 to 450 MPa by 
using an Avure PT-1 pressure unit. There was no virus inactivation at low 
pressure levels (50 to 200 MPa), and inactivation was found the pressure was 
increased above 550MPa. Results showed the HHP inactivation of GI.1 which 
showed the maximum of ~3 log reduction at 21°C natural PH under 550MPa and 
21°C PH 4 under 550MPa. GII.4 had a maximum reduction of ~3.5 log10 units at 
both 4°C and 21°C natural PH under 250MPa (Table 4). However, increasing the 
pressure did not result in greater reduction. Both the GI.1 and the GII.4 strains 
were more sensitive to pressure at 4°C than at 21°C, along with neutral pH than 
at pH 4. It can be consulted that the GI.1 strain was more resistant to pressure 
than the GII.4 strain addressed Li in 2015.  
 
In another study, it was found that HHP inactivation on HuNoV GI.1 and GII.4 
strains under different pressure levels and temperatures were obtained using the 
direct RT-qPCR, PGM/PCR and PMA/ PCR assays (Li et al., 2017). HuNoV 
GI.1, and HuNoV GII.4 samples were HHP treated at 50–300, 250–550, and 100–
400 MPa, respectively. HHP treatments were conducted at initial sample 
temperatures of 4 and 21 °C for 2 min using an Avure PT-1 pressure unit. Except 
for the HHP treatment of HuNoV GI.1 at 21 °C, direct RT-qPCR showed a <1.0 
log10 reduction at all pressure level. At 500MPa pressure levels at 21°C, the 
PMA/PCR assay showed >2.5 log10 reduction of HuNoV GI.1 and ~1.7 log10 
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reduction at PGM/ PCR assay shown in Table 4. At 400MPa pressure levels at 
21°C, the PMA/PCR assay and PGM/ PCR assay both showed >2.5 log10 
reduction of HuNoV GI.1. For HuNoV GII.4, a maximum inactivation (~3.5 log10 
reduction) was observed for both the PGM/PCR and PMA/PCR assays. The 
direct RT-qPCR showed much lower inactivation effect of HuNoV comparing to 
the other two assays. It could be logically concluded that the PGM/PCR and 
PMA/PCR assays were both better than the direct RT-qPCR assay. 
 
VIRUS
ES 
INACTIVA
TION 
AGENT 
RANGE OF 
CONCENTRA
TIONS OR 
TREATMENT
TIME 
QUANTIFICA
TION 
METHOD 
RANGE 
OF 
REDUCTI
ONS 
REFERE
NCE 
GI HPP 500, 600MPa for 
45 min. 
700 and 800 for 
30 min 
900 MPa for 
2min 
SDS-PAGE 500, 600 
MPa: 
notably 
reduced. 
700 MPa: 
undetectable 
800, 
900MPa: 
undetectable. 
(Lou et al., 
2012) 
GII HPP 500, 600 and 
700MPa for 45 
min. 
800 for 45 min 
900 MPa for 
2min 
SDS-PAGE 500, 600 
and 700 
MPa: still 
intact 
800 and 900 
MPa: 
dramaticall
y decreased 
(Lou et al., 
2012) 
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Table 4. High pressure inactivation of HuNoVs   
 
1.6. Other Human Norovirus Inactivation Studies 
Another study in 2017 (Li et al., 2017) compared the heat and HHP using HuNoV GI.1 
strain and a GII.4 strains under different temperatures. The virus was evaluated using those 
different molecular assays by using the direct RT-qPCR, PGM/PCR, and PMA/PCR assays. 
For GI.1, the direct RT-qPCR assay showed no inactivation for all heat treatments at 60 to 
90°C. The PGM/PCR assay and PMA/PCR assay showed different inactivation result. For 
example, for a 2min heat treatment at 90°C, PGM/PCR assay showed a 2.2 log10 reduction 
(Table 5) while PMA/PCR assay showed no inactivation (0-1.2 log10 reduction) from 60 to 
80°C. The PGM/PCR assay showed a when increase of heat inactivation effect of GI.1 from 
60 to 70°C followed by increase from 70 to 90°C (1.2 to 2.1 log10 reduction). As for HuNoV 
HuNoV
s 
HHP 200, 300, 350, 
400, 450, and 
500 MPa for 
15min 
RT-qPCR 
 
<0.5 log10 (Sanchez 
et al., 
2011) 
GI.1 
GII.4 
HHP on 
green onions 
and salsa 
600MPa and 
500MPa (GI.1) 
500 MPa and 
300MPa (GII.4) 
RT-qPCR >3 log10 
reduction 
(Sido et 
al.,2017) 
GI.1 
GII.4 
HHP At 21°C with 
natural ph. and 
ph. 4 
550MPa (GI.1) 
250MPa (GII.4) 
PGM/PCR 
PMA/PCR 
RT-qPCR 
3.8 log10 (Li et al., 
2015) 
GI.1 
GII.4 
HHP 400 and 500MPa 
At 21°C 
PGM/PCR 
PMA/PCR 
GI.1: >2.5 
log GII.4: 
~3.5 log10 
(Li, et al., 
2017) 
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GII.4, all three assays showed similar inactivation results, almost no inactivation of GII.4 
from 60 to 80°C. 
 
One study applied sodium metasilicate and sodium hypochlorite to fresh vegetables (Ha, et 
al., 2017). The research evaluated the efficacy of a range concentrations of 50-1000 ppm 
NaOCl, for reducing the amounts of HuNoV GII.4 on lettuce, celery, and white cabbage. 
The reductions of GII.4 were 3.17, 3.06, and 3.27 log10 reduction for lettuce, celery, and 
cabbage, respectively, at 1000 ppm NaOCl, while a reduction of similar to 3 log10 reduction 
was obtained when the samples were treated with 100ppm NaOCl combined with 0.4% 
SMS pentahydrate (Table 5). Taken together, these results demonstrated that combined 
treatment with NaOCl and SMS pentahydrate was an efficient antimicrobial to reduce the 
concentration of NaOCl for HuNoV GII.4 contamination in fresh vegetables. 
 
The stability and attachment to lettuce has also been observed. (Wang et al., 2012). The 
results have showed that after incubation for 30min at 56°C, HuNoVs has low effect but it 
changed significantly after 2 hours treatment, with a < 1.0 log10 reduction in both 
GII.12/HS200 and GII.4/HS194. In the ethanol treatment, strains were treated with two 
commonly used concentrations of ethanol, 60% and 70%, at room temperature for 5min, 
the results showed the RNA reduce with 1.51±0.15 and 1.37±0.32 log10 unites compared to 
water control. The resistance to chlorine treatment of HuNoVs showed that both virus’ RNA 
became undetectable after sodium hypochlorite concentrations were increased to 200 mg/l. 
 
In 2013, PGM-MB were used to inactive HuNoVs (Kingsley et al., 2014). The ability of 
HuNoV to bind to PGM-MBs was assessed after 1min treatments with effective 
concentrations of 33, 173, and 189 ppm of chlorine, respectively. As compared to the 
22 
 
untreated control, log10 reductions were 1.48 ± 0.42, 3.65 ± 0.41, and 4.14 ± 0.54, 
respectively. Initially, concentrations of 240 ppm chlorine dioxide were evaluated for 1 min. 
However limited inactivation (~0.33 log10) was observed. Consequently, 240 ppm ClO2 
treatments were extended to up to 60 min. Results indicated that 10, 30, and 60 min 
treatments with 240 ppm ClO2 gave 0.8 ± 0.24, 1.5 ± 0.42 and 2.8 ± 1.27 log10 reduction 
(Table 5), respectively. For 4% concentration of H2O2, exposing HuNoV for 1 min, a low 
log10 reduction (~0.1 log10) was observed. The effect of trisodium phosphate (TSP) was also 
evaluated by mixing 5% TSP with HuNoV for 5, 15, and 30min treatments followed by 
PGM-MB and qRT-PCR assay. Results indicated that exposure to 5% TSP for 5min was 
reduced binding by 1.6 ± 0.58. log10. When increased the contact time to 15 and 30min, did 
not result in substantially greater reductions.  
 
In 2010, HuNoV was inoculated into chlorination and bench-scale free chlorine that 
performed for 0.1 and 0.5 mg l -1 concentrations, (Kitajima et al., 2010). At free chlorine 
concentrations 0.5 mg l -1, a reduction in HuNoV from 1.10 to 3.64 log10 after contact time 
(5 to 30 min) using the direct RT-qPCR while at 0.1mg l -1 achieved less than 0.1 log10 
reduction after 30 min contact time (Table 5). Viral RNA titer was almost constant 
regardless of the virus type. The results indicating similar persistence against free chlorine 
disinfection. Recent studies also demonstrated that MNV was more sensitive to free chlorine 
than other enteric viruses, and that HuNoV is not highly resistant to free chlorine 
disinfection. 
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VIRUS
ES 
INACTIVA
TION 
AGENT 
RANGE OF 
CONCENTRA
TIONS OR 
TREATMENT
TIME 
QUANTIFICA
TION 
METHOD 
RANGE 
OF 
REDUCTI
ONS 
REFERE
NCE 
GI.1 
GII.4, 
Heat 2min at 90°C PGM/PCR 
PMA/PCR 
2.2 log10 
(GI.1) 
No 
inactivation 
(GII.4) 
(Li et al., 
2017) 
GII.4 NaOCl on 
lettuce, 
celery, and 
cabbage 
1000 ppm RT-qPCR 3.17, 3.06, 
and 3.27 
log10 
(Ha, et al., 
2017) 
GII.4 NaOCl and 
0.4% SMS 
pentahydrate 
on lettuce, 
celery, and 
cabbage 
100ppm RRT-qPCR 3 log10 (Ha et al., 
2017) 
GII.4 Heat 
inactivation 
Incubation at 
56°C for 2 hours 
RT-qPCR < 1.0 log10 (Wang et 
al., 2012) 
GI.1 
GII.4 
60% and 
70%, ethanol 
Room 
temperature for 5 
min. 
PGM-MB 
assay, RT-qPCR 
1.51±0.15 
and 
1.37±0.32 
log10 
(Wang et 
al., 2012) 
GI.1 240 ppm 
ClO2 
10, 30, and 
60min 
RT-qPCR, 
PGM/PCR 
0.8 ± 0.24, 
1.5 ± 0.42 
and 2.8 ± 
1.27 log10 
(Kingsley 
et al., 
2014) 
GI.1 5% trisodium 
phosphate 
5min PGM-MB 
qRT-PCR 
1.6 ± 0.58. 
log10 
(Kingsley 
et al., 
2014) 
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Table 5 Other HuNoVs inactivation studies 
 
1.7. Conclusion 
HuNoV GI and GII type of cause outbreaks among the population with majority 
coming from GII.4. It is important to improve and understand methods of 
inactivate to prevent these outbreaks on food and otherwise. Although many 
researches have tested in vitro and in vivo cultivation methods, many methods 
still have limitation on HuNoVs viral reduction. As Inactivation of HuNoVs has 
been seen on a multitude study, for example, inactivation in solution, surfaces, 
high pressure and other inactivation; washing with soap shown the highest 
inactivation (>6 log10 reduction) in the review. Sodium hypochlorite (hand 
soap), NEW on hard surfaces also showed >4 log10 reduction on HuNoVs 
genome copies. Additionally, when inactivation in solution, 13% chlorine and 
1000 ppm of 90% ethanol were achieved >4 log10 reduction. However, some of 
inactivation methods showed the limited viral inactivation. For example, 200-500 
MPa pressure level after 15 min HHP treatment on HuNoV achieved <0.5 log10 
reduction also a 0.5 log10 reduction of HuNoV GII.4 after exposure to 50% 
isopropanol. HuNoVs are resistant to quantification of different solutions is 
GI.1 4% H2O2 1min PGM-MB 
qRT-PCR 
~0.1 log10 (Kingsley 
et al.,2014) 
HuNoV Chlorine 0.1 mg l -1 120 
min 
0.5 mg l -1 5-30 
min 
qRT-PCR 0.1 mg l -1 
120 min: 
3.84 log10 
0.5 mg l -1 5 
to 30 min: 
1.10 to 3.64 
log10 
(Kitajima 
et al., 
2010) 
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important for identifying agents that may be of more practical value in an applied 
setting. Furthermore, the limitation of inactivation showed different sensitivity to 
HuNoV strains GI and GII should be conducted. In addition to HuNoV existing 
features as a near-perfect foodborne pathogen, we need to find more efficient 
method even in vitro and in vivo cultivation because HuNoVs are so difficult to 
study. 
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CHAPTER 2  
GENERATION OF POSITIVELY CHARGED CARVACROL 
NANOEMULSIONS AND THEIR SHELF LIFE 
2.1. Abstract 
Due to the low solubility of carvacrol in water, carvacrol must be delivered as a 
nanoemulsion. In this study, we applied a low energy method (spontaneous 
emulsification) to generate nanoemulsions containing carvacrol, medium chain 
triglyceride (MCT) and surfactant. The most optimal carvacrol nanoemulsion 
contained 10% (v/v) organic phase (0.33 to 1.0% carvacrol, 4.67 to 4.0% MCT, 
and 5.0% Tween 80, v/v) and 90% aqueous phase (RNase-DNase-Free water 
with 0.02% CTAB), and was produced at room temperature by spontaneous 
emulsification. In order to enhance delivery application, we applied the 
Cethyltrimethylammonium bromide (CTAB) to make the nanoemulsion contain 
a positive charge, thus increasing the delivery of the carvacrol nanoemulsion to 
negatively charged biological molecules of interest. The droplet size was 
decreased (from d ≈ 200 to d ≈ 95 nm) and the mean Zeta-potential stay stable 
(mean value from 11.0 to 13.0 mV) when carvacrol concentration was increased 
from 0.33 to 1.0% (and MCT was decreased from 4.67 to 4.0% v/v). For 14 days 
shelf life study, 0.5% carvacrol nanoemulsions droplet sizes and Zeta-potential 
were examined at three different temperatures reflecting different potential 
applications (37°C, 20°C and 4°C). The mean droplet size and Zeta-potential 
were stable at three different temperatures for the duration of the test. The results 
of this study inform the design and utilization of spontaneously formed, 
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positively charged carvacrol nanoemulsions and the extent of their stability in a 
number of different applications. 
2.2. Introduction 
Nanoemulsions are emulsions with droplet size on the order of 1 to 100 nm. A 
typical nanoemulsion contains oil, surfactant and water. In order to prepare a 
stable and smaller droplet size (d ≈ 100nm) of nanoemulsion, the droplet size, 
stability and solubility were found to be dependent on the composition of 
carvacrol nanoemulsion (type of surfactant, concentration of oil phase, ratio of 
carvacrol to carrier oil, etc.) as well as the type of food matrix where the 
carvacrol nanoemulsion is applied (Chang et al., 2013; Donsì et al., 2012). 
 
Compared to oil-in-water emulsion, much more work can be done to understand 
the behavior and stability of spontaneously formed nanoemulsions containing a 
number of natural bioactive compounds in the light of increasing consumer 
demand for “natural” products. The growing demand for the use of natural 
additives has produced a substantial increase in the number of studies based on 
natural extracts such as carvacrol or its main compounds in the last decade. 
Carvacrol are categorized as Generally Recognized as Safe (GRAS), and are 
therefore potential alternatives to chemical additives (Sanchez et al.,2015; 
Mason et al., 2006).  
 
The food industries have paid attention to the natural alternatives to assure food 
safety and quality. Oregano is a natural food additive which bioactive 
components are beneficial as flavoring or seasoning agents in some of the most 
accepted cuisines around the world. Additionally, oregano oil is attributed to 
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antioxidant effect from their major components, carvacrol and thymol, and it is 
the result of various possible mechanisms: free-radical scavenging activity, 
transition-metal-chelating activity, and/or singlet-oxygen- quenching capacity 
(Shan et al., 2005).  
 
Carvacrol are considered to present no risk to the health of consumers and have 
been registered by U.S. Food and Drug Administration and generally recognized 
as safe components (Burt et al., 2004). Additionally, carvacrol and thymol are 
the main antimicrobial and antioxidant monoterpene phenolic compounds that 
constitute 78–85% of oregano (Govaris et al., 2010). Its components are 
potential natural food antimicrobials, which can meet the increasing demands of 
fresh and chemical-additive-free food products from more health-conscious 
consumers and legal authorities (Smith-Palmer et al., 1998). Moreover, the anti-
inflammatory potential of essential oils containing carvacrol and itself have been 
investigated in details in various models of inflammation (Hotta et al., 2010; 
Lima et al., 2013). Furthermore, another group (Lima et al., 2013) also 
demonstrated that carvacrol exerts presets anti-inflammatory activity on a typical 
mice inflammation model. 
 
Over the past decade or more, the research focus has been on preparing 
nanoemulsions through various methods, broadly classified into two primary 
categories: high-energy and low-energy methods. High-energy methods utilize 
mechanical devices that are capable of disrupting and intermingling the oil and 
aqueous phases into tiny oil droplets dispersed in water. Low-energy methods 
mainly rely on the spontaneous formation of droplets at the interface between oil 
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and water phases and depend strongly on the nature of any surface-active 
molecules present, e.g., their solubility and molecular geometry (Chang et al. 
2013). Low energy approaches may have advantages over high-energy 
approaches for certain applications: they are often more effective at producing 
desired droplets, they have lower equipment and energy required, and they are 
simpler to implement (Chang et al., 2013). 
 
By contrast, nanoemulsions do not form spontaneously; an external shear must 
be applied to separate larger droplets into smaller droplet. In this study, we 
examine the potential of using the spontaneous emulsification method (low-
energy method) for producing carvacrol nanoemulsions. In general, this method 
involves pouring an organic phase (containing oil and surfactant) into an aqueous 
phase, which leads to the spontaneous formation of desired droplets due to rapid 
diffusion of the surfactant from the oil phase into the aqueous phase (Anton et 
al., 2009). The movement of the hydrophilic surfactant from the oil phase to the 
aqueous phase after mixing leads to the spontaneous formation of desired oil 
droplets at the oil−water boundary. This method allows nanoemulsions to be 
produced at room temperature using simple stirring rather than expensive 
homogenization equipment (Chang et al., 2013). 
 
Nanoemulsions are kinetically stable, but given sufficient time, will separate into 
different phases. The different destabilization mechanisms of nanoemulsions are 
primarily flocculation, coalescence, and Ostwald ripening. In flocculation, 
droplets come closer to each other because of attractive interactions and move 
as a single entity. In contrast, in coalescence, the droplets merge into each other 
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to become a bigger droplet. Ostwald ripening occurs due to the difference in 
chemical potential of solute within droplets of different sizes. The chemical 
potential of the dispersed phase provides the driving force for mass transfer from 
the smaller to the larger droplets. Thus, the smaller droplets become smaller and 
the larger droplets grow (Gupta et al., 2016).  
 
To make stable nanoemulsions, we can apply MCT to stabilize nanoemulsions 
due to its highly nonpolar nature. In this study, MCT was beneficial not only for 
the spontaneous formation of carvacrol nanoemulsions but also for ensuring their 
shelf life stability test, to avoid Ostwald ripening and coalescence inhibitor 
(Chang et al., 2013). The addition of nonpolar triglyceride oils (such as MCT) 
may therefore have decreased the coalescence rate by decreasing the polarity and 
increasing the interfacial tension. An alternative approach to enhancing the long-
term stability of nanoemulsions would be to store the antimicrobial as an organic 
phase containing carvacrol and carrier oil (MCT) and then add this organic phase 
to an aqueous product when needed (Chang et al., 2013). 
 
The addition of surfactant is critical for the creation of small sized droplets as it 
decreases the interfacial tension i.e., the surface energy per unit area, between 
the oil and water phases of the emulsion (Gupta et al., 2016). Carvacrol oil-in-
water nanoemulsions can also stabilized by a nonionic surfactant (Tween 80). 
Tween 80 dissolved in sterile deionized distilled water will be prepared to 
determine the optimum interfacial composition to obtain small stable droplets 
with high antimicrobial efficacy. The decrease in droplet size is because of the 
accumulation of surfactant molecules at the interface which leads to increase in 
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the interfacial area and decrease of the interfacial energy (Tadros et al., 2004). 
 
Cethyltrimethylammonium bromide (CTAB) is a cationic surfactant that self-
assembles as micelles, and other structures and phases depending on the 
concentration and solvent characteristics. CTAB is appropriate for extraction of 
biomolecules, since its cationic micelles are stable over a wide range of pH 
(J¨onsson et al., 1998). Moreover, addition of a cationic surfactant to emulsions 
can further enhance functionality and delivery to negatively charged target 
molecules; for instance, it can enhance antimicrobial activity against bacteria by 
better delivering antimicrobial to the negatively charged cell surface (Ziani et 
al., 2011).  
2.3. Materials and Methods 
2.3.1. Carvacrol Nanoemulsion Materials 
Purified carvacrol (>98%) was purchased from Sigma-Aldrich (St. Louis, 
MO). Organic MCT oil was purchased from Nature's Way (Green Bay, WI). 
Polyoxyethylene-80 (Tween 80) and Hexadecyltrimethylammonium 
bromide (CTAB) were purchased from (Markham, ON). Sterile RNase-
DNase-Free water and Phosphate-buffered saline (PBS) were purchased 
from Thermo Fisher (Waltham, MA). 
2.3.2. Nanoemulsion Preparation 
Initially, to make carvacrol nanoemulsions, we first prepared aqueous phase 
and lipid phase separately. Organic phases were prepared by mixing different 
concentration (0.33, 0.5 or 1.0% v/v) of purified carvacrol, different 
concentrations of MCT (4.67, 4.5 or 4% v/v) and 5.0% Tween 80 were added 
to make a total organic phase of 10% (v/v) by using a stir bar for 15min at 
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room temperature. The aqueous phase used to prepare the nanoemulsions 
consisted of 0.02% of CTAB dispersed in 50ml of nuclease-free distilled 
water at room temperature. The organic phase (10% v/v) was added then 
mixed with aqueous phase (90% v/v) by using a manual dispenser 
(Repeater® M4, Eppendorf, Hauppauge, NY). All components were mixed 
for 30 min at 25°C. 
2.3.3. Nanoemulsion Shelf Life Test 
For the purposes of shelf life testing, a 0.5% carvacrol nanoemulsion was 
evaluated, by generation of two nanoemulsions sealed in 100ml conical 
flasks and then separately stored at 4°C, 20°C and 37°C for 14 days. We 
separately tested each nanoemulsion sample (from 4°C, 20°C and 37°C 
incubators and in each condition has two samples) at days 1, 3, 7 and 14 
2.3.4. Droplet Size and Zeta-Potential Measurement 
The particle size and zeta-potential of the nanoemulsions were determined 
using (Zetasizer Nano ZS, Malvern Instruments, Worcestershire, UK). 
Samples were diluted to an oil droplet concentration of 5.0% (v/v) using the 
same buffer (nuclease-free distilled water) as the original sample to eliminate 
multiple scattering effects. A measured refractive index value of 1.456 for 
the 0.5% carvacrol mixed with 4.5% MCT was used. The refractive index of 
the mixed oil phase was calculated by the mass fraction on a Refractometer 
(Bausch & Lomb, Rochester, New York). The droplet size and Zeta-potential 
were used to represent the mean particle diameter and surface potential of 
the lipid droplets. After 60s of equilibrium, each sample was scanned three 
times and the average was recorded. The Z-Average and Zeta-potential were 
used to represent the mean particle diameter and surface potential of the lipid 
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droplets. 
2.3.5. Statistical Analysis 
Nanoemulsion preparation experiments, Z-averages, and Zeta-potential 
measurements were performed in triplicate on freshly prepared samples. 
Nanoemulsion stability to shelf life test were tested from two samples at 
different temperature environment by following manufacturer instructions at 
60 seconds. The results were then reported as averages and standard 
deviations of these measurements. 
2.4. Results 
2.4.1. Z-Average and Zeta-Potential of Oil Phase Composition on Nanoemulsion 
Formation 
The mean droplet diameter decreased from 220.8 nm to 112.3 and 95.5 nm 
when the carvacrol concentration was increased from 0.33 to 0.5 and 1.0% 
(Table 6) after combination with 4.67, 4.5 and 4.0% MCT and 5.0% Tween 
80 and 90% aqueous phase, respectively. The mean Zeta-potential stayed 
relatively stable, with mean values from (+)11.0-13.0 for the above 
variations in conditions.  
 
Carvacrol oil 
% 
MCT % Tween 80 
% 
Aqueous phase 
% 
Mean droplet 
diameter (nm) 
Mean Zeta-
potential (mV) 
0.33 4.7 5.0 90.0 220.8 11.3 
0.5 4.5 5.0 90.0 112.3 13.0 
1.0 4.0 5.0 90.0 95.5 11.0 
 
Table 6. Effect of mean droplet diameter and mean Zeta-potential of carvacrol oil 
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nanoemulsions fabricated combining with differing MCT concentration. 
2.4.2. Storage Stability of 0.5% Carvacrol Nanoemulsions 
We examined the influence of storage time on the stability of 0.5% carvacrol 
nanoemulsions that were found to be stable to visible creaming over 14 days 
at three different temperature (4°C, 20°C and 37°C). These systems consisted 
of an oil phase (10% v/v) of 5% oil (0.5% carvacrol and 4.5% MCT), 5% 
surfactant (Tween 80), and 90% aqueous phase (included nuclease-free 
distilled water and 0.02%CTAB). Initially, these systems had different mean 
diameters due to the influence of oil phase composition on the efficiency of 
nanoemulsion formation. When 0.5% carvacrol nanoemulsion storage at 37°C 
(body temperature for potential nutritional applications), the mean diameter 
(Fig. 1) were relatively stable, ranging from 130.4-294.9 nm over 14 days. At 
20°C (room temperature condition), mean diameter (Fig. 1) were also 
relatively stable, ranging from 221.7-295.5 nm over 14 days. The mean 
diameter (Fig. 1) were also relatively stable at 4°C, ranging from 215.7-277.8 
nm over 14 days as similar results to 37°C and 20°C 
 
The mean Zeta-potential (Fig. 2) were stable, the ranging from (+)12.1-17.9 
mV over 14 days at 37°C. At 20°C and 4°C, the Zeta-Potential results were 
similar to storage at 37°C, ranging from (+)14-18.7 mV over 14 days. 
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Fig. 1. 0.5% nanoemulsion shelf-life study on Z-Average. Z-Average stays stable in mean 
particle diameter of selected nanoemulsions during 14 days of storage at three different 
temperature. Nanoemulsions were prepared using 5% oil (carvacrol + MCT of varying 
ratios), 5% surfactant (Tween 80), and 90% aqueous phase (included deionized distilled 
water and 0.02%CTAB) at a stirring speed of 700 rpm at ambient temperature (25 °C). 
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Fig. 2. 0.5% nanoemulsion shelf-life study on Zeta-Potential. Zeta-Potential is stable with 
mean particle diameter of selected nanoemulsions during 14 days of storage at three 
different temperature. Nanoemulsions were prepared using 5% oil (carvacrol + MCT of 
varying ratios), 5% surfactant (Tween80), and 90% aqueous phase (included deionized 
distilled water and 0.02%CTAB) at a stirring speed of 700 rpm at ambient temperature 
(25 °C) 
2.5. Discussion 
Initially, we examined the influence of organic and aqueous phase composition 
on the initial size of the oil droplets and Zeta-potential in positively charged 
nanoemulsions produced using spontaneous emulsification. Organic phase 
composition was varied by combining different mass ratios of carvacro) and 
MCT prior to emulsification. A present study (Flores et al., 2016) have applied 
0.5% (v/v) carvacrol concentration with Tween 80 along with high-pressure 
homogenization that generated emulsions with smaller droplet size, lower 
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polydispersity index, and higher Zeta-potential. The presence of carvacrol and 
Tween 80 in the emulsions and the use of high-pressure homogenization 
decreased the emulsion contact angle because of the smaller droplet size and its 
greater surface interaction, thus improving its wettability properties. 
 
Therefore, the lower concentrations (0.33, 0.5 and 1.0%) of carvacrol 
nanoemulsion were made in our study. The overall system composition reflected 
what has previously been reported 5.0% oil phase (carvacrol + MCT), 5.0% 
surfactant (Tween 80) and 90% aqueous phase (includes 0.02% CTAB). As the 
carvacrol concentration in the oil phase increased (from 0.33 to 0.5 and 1.0% 
v/v), the mean droplet diameter initially decreased (Table 6). To maintain a 
droplet size within the range generally desired for nanoemulsions, we adjusted 
the ratio between carvacrol and MCT (oil phase). For example, (Chang et al., 
2013) presented the systems containing 2.5% carvacrol and 7.5% MCT (25% 
carvacrol and 75% MCT in oil phase) in the total nanoemulsion was created. In 
this work, the composition of three different concentrations of nanoemulsion 
were 0.33% (6.6% carvacrol and 93.4% MCT in oil phase), 0.5% (10% carvacrol 
and 90% MCT in oil phase) and 1.0% (20% carvacrol and 80% MCT in oil phase) 
formed mean droplet sizes of 220.8, 12.3 and 95.5 nm. This finding is in 
agreement with previous studies of nanoemulsion formation using spontaneous 
emulsification, as larger droplets can occur when too much MCT is added to the 
oil phase because the efficiency of spontaneous emulsification decreases. 
Consequently, an optimum MCT level is required (around 40%) to form stable 
nanoemulsions (Ryu et al., 2018).   
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In order to add delivery functionality, we applied 0.02% CTAB to give the 
nanoemulsions a positively charged nanoemulsion which exhibited stable and 
consistent Zeta-potential with three different concentrations (0.33, 0.5 and 1.0% 
v/v) of carvacrol nanoemulsions. The mean Zeta-potential generally did not 
fluctuate with different formulations, mean values from +11.3, +13.0, and 11.0 
mV when the carvacrol concentration was increased from 0.33 to 0.5 and 1.0% 
(Table 6), respectively. Since droplet charge may have an important impact on 
nanoemulsion stability and antimicrobial efficacy, a recent study (Chang et al., 
2015) showed that a 0.1% cationic surfactant was added in thyme nanoemulsion 
became positive charged (+18 mV), suggesting that at least some of the cationic 
surfactant molecules adsorbed to the oil droplet surfaces.  
 
Overall, our shelf life study suggested that the nanoemulsions will likely stay 
stable in multiple application temperatures, ranging from refrigeration to body 
temperature (Fig. 1). As nanoemulsion droplet size stayed stable (from d >100, 
d < 300 nm) at three different temperatures (4°C, 20°C and 37°C) over 14 days.  
 
At 4°C, the mean sizes ranged from 215.7-260.9 nm for days 1-14, then rapidly 
decreased by day 21 to 130.4 nm. This result is largely in agreement with (Chen 
et al., 2018) which presented their nanoemulsion with 10% carvacrol in oil phase 
was stable (d ≈ 150 nm) at 4°C in 28 days shelf life test. 
 
 At 20°C, the mean sizes appeared very similar to 4oC, with sizes ranging from 
222.7-264.1 nm for days 1-14. Another carvacrol nanoemulsion systems in study 
(Chang et al., 2013), consisted of 10% carvacrol in oil phase (90% MCT in oil 
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phase) that were found stable (d ≈ 5 nm) at ambient temperature (25°C) for 30 
days shelf life test.  
 
When 0.5% carvacrol nanoemulsion storage at 37°C in this study, the mean 
diameter (Fig. 1) ranging from 130.4-294.9 nm over 14 days. Currently, there is 
no study presented carvacrol nanoemulsion (at desired concentration of 10% 
carvacrol in total oil phase) on 37°C for long term study. However, the study 
(Dey et al., 2018) demonstrated that a different type of nanoemulsion 1.5% (w/v) 
ω-3 PUFA rich fish oil plus 1% (wt /v) total surfactant (Tween 20 + Span 80) 
performed nanoemulsion oil droplet size (d ≈ 175 nm) stable at 37°C for 4 weeks. 
  
To our knowledge, no prior studies have reported the behavior and shelf life of 
positively charged carvacrol nanoemulsions at different temperatures from 
different applications. Nevertheless, the mean Zeta-Potential (Fig. 2) fluctuated 
slightly but stayed stable (+12.1 to +18.7 mV) at three different temperatures 
(4°C, 20°C and 37°C) on 14 days shelf life test in this study. It is due to the fact  
in a more recent study (Kumar et al., 2018) exhibits the successful selection of 
Tween 80 surfactant from given CTAB by characterization on the basis of their 
surface active for stabilizing oil-in-water nanoemulsions  
 
Overall, the 0.5% carvacrol nanoemulsion droplet size and Zeta-potential 
remained relatively stable at three distinct temperatures (4°C, 20°C and 37°C) 
for 14 days shelf life test. This is likely due to a higher amount (90% in total lipid 
phase) of MCT enhancing the long-term stability (Chang et al., 2013). In order 
to attempt to create smaller oil droplet size, we may increase the carvacrol 
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concentration (30 to 40%) in total lipid phase while lower the MCT 
concentration (70 to 60%) in total lipid phase. However, previous reports suggest 
that this may give the nanoemulsion unstable when more than 25% of carvacrol 
(in total oil phase) is used cause unstable nanoemulsions (Chang et al., 2013). 
2.6. Conclusion 
In sum, we optimized the formulation of and investigated the behavior of 
positively charged, spontaneously formed carvacrol nanoemulsions. Further, we 
evaluated the shelf life of these nanoemulsions at different potential application 
temperatures (refrigeration, room, and body temperature). In the wake of 
growing consumer demand for different “natural” products in a number of 
industries, our study broadly informs the development and study of 
functionalized carvacrol nanoemulsions that can be cheaply fabricated and are 
stable in a range of application temperatures. 
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CHAPTER 3  
CARVACROL NANOEMULSION ANTIMICROBIC EFFICACY ON 
BACTERIOPHAGE MS2 AND ESCHERICHIA COLI 
3.1. Abstract 
The essential oils in plants contain complex mixtures with lipophilic and volatile secondary 
metabolites. The antimicrobial active ingredient of essential oils can be the dominant 
component, greater than 50% of the chemical composition in many cases. Additionally, the 
natural plant antimicrobials have a higher acceptance at public, therefore the natural 
essential oil active ingredients have been investigated for application on food to reduce 
microorganism transmission. Carvacrol has previously been demonstrated to have a 
moderate antiviral effect on noroviruses. Previous work has also demonstrated that 
restructuring essential oils in positively charged nanoemulsions can enhance their 
antimicrobial efficacy. The purpose of this work was to investigate if restructuring 
carvacrol in positively charged nanoemulsions could enhance the antinoroviral efficacy of 
carvacrol. Carvacrol nanoemulsions (0.5, 0.83% v/v) were dissolved in Dulbecco's 
phosphate-buffered saline (DPBS), and the median particle size was 122.7nm and 123nm—
acceptable for nanoemulsions—and the median Zeta potential were -1.42 and -1.15mV at 
0.5 and 0.83% carvacrol. Carvacrol nanoemulsions at 0.5 and 0.83% both displayed 
negligible viral reduction. Therefore, we investigated efficacy with different aqueous phase 
(nuclease-free distilled water) for dissolving carvacrol nanoemulsion. Due to carvacrol’s 
low solubility in water, different concentrations of carvacrol nanoemulsion (0.5, 1.0% v/v) 
were produced by a low energy method (Nano-emulsification) in nuclease-free distilled 
water instead of DPBS. The median particle sizes were 112.3nm and 71.5nm, and Zeta-
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potential were +12.9 and 9.6mV. When applied against MS2, carvacrol nanoemulsion 
(0.5%, 1.0% v/v carvacrol) with 60 min; 0.5% carvacrol nanoemulsion showed no 
reduction on MS2. However, 1.0% carvacrol nanoemulsion showed a 0.73 log reduction of 
MS2. In bacteria antiviral efficacy, carvacrol nanoemulsions (1.0% v/v) dissolved in 
nuclease-free distilled water leading to 0.35 log reductions of Escherichia coli after 15 min 
contact time. However, when contact time was increased to 30 and 60min, the treatment 
showed no log reduction of Escherichia coli. 
3.2. Introduction 
HuNoV is a major leading cause of foodborne illness, and now this pathogen is recognized 
as a leading cause of diarrhea for all ages of person. (Patel et al., 2009). NoVs are 
nonenveloped single-stranded RNA virus. The viral capsid typically is 27- 35 nm in 
diameter, and has a 7.5-7.7-kilobase in length of positive-sense genome that consists of 
three open reading frames (ORFs) (Glass et al., 2000; Jiang et al., 1993; Lambden et al., 
1993). ORF1 codes for a non-structural polyprotein, ORF2 and ORF3 codes major (VP1) 
and minor (VP2) capsid proteins, respectively (Glasset et al., 2000; Prasad et al., 1999). The 
viruses have an icosahedral capsid that contain of 180 copies of the VP1 that self-assemble 
based on hydrophobic contacts, and the pI of VP1 makes it negatively charged in neutral 
pH (Smithet et al., 2019). One of the major challenges is their general resistance to many 
commonly used inactivation agents (Hirneisen et al., 2010) and the lack of natural 
disinfectants can efficiently inactive for norovirus capsid (Kamarasu et al., 2018). Therefore, 
we applied novel spontaneous Nano-emulsification method to form a carvacrol 
nanoemulsion against bacteriophage MS2 and E. coli. 
 
The carvacrol with higher antibacterial properties contains a high percentage of phenolic 
compounds, causing irreversible damage to the bacterial membrane proteins and membrane 
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(Donsì et al., 2014). However, essential oils and their active components have only 
displayed moderate inactivation of noroviruses surrogate (<1-3 log10 reduction on MNV), 
therefore no food-grade, natural inactivation agents currently used in foods or on food 
contact surfaces (Gilling et al., 2014).  
 
Since the water solubility of carvacrol is as low as 0.11-0.83 g/l at room temperature (Chen 
et al., 2014), it is difficult to directly inactivate MS2 by only using carvacrol in a disinfectant 
solution. Although NoV do not have a lipid membrane, we hypothesize the positively 
charged nanoemulsions will still better deliver carvacrol to the negatively charged viral 
capsid that has hydrophobic contacts that hold the capsid together.  
 
Nanoemulsions can enhance delivery of the active component against environmental 
stresses and increase the partition of the hydrophobic component to aqueous phase (Chang 
et al., 2013). The antimicrobial activity of carvacrol was found to be dependent on the 
composition of nanoemulsion (type of surfactant, concentration of oil phase, aqueous phase 
and ratio between carvacrol and MCT). The desired nanoemulsion droplet size and the 
solubility properties are defined to formulate a nanoemulsion. Additionally, the study 
(McClements et al., 2011) proved a small particle size of nanoemulsion (100nm-1000nm) 
that can improve physical stability and increased bioactivity of lipophilic active ingredients 
 
Many essential oils have lower water solubility, which can lead to rapid nanoemulsion 
destabilization through a phenomenon known as Ostwald ripening, i.e., diffusion of the oil 
from small droplets to large droplets. Eventually, this leads to oil and aqueous phase 
separation, therefore the nanoemulsion may become unstable. Addition of highly lipophilic 
triglycerides (such as MCT) can prevents Ostwald ripening and stabilizes essential oil 
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nanoemulsions (Ziani et al., 2011). 
 
Carvacrol oil-in-water nanoemulsions can stabilized by a nonionic surfactant (Tween 80), 
Tween 80 dissolved in sterile deionized distilled water will be prepared to determine the 
optimum interfacial composition to obtain the stable and smaller droplets with high 
antimicrobial efficacy. Addition of a cationic surfactant to nanoemulsions further enhances 
antimicrobial activity (Ziani et al., 2011). The mechanism of antibacterial action of essential 
oil is mainly based on the hydrophobicity of their constituent molecules. Indeed, the 
essential oil with higher antibacterial properties contain a high percentage of phenolic 
compounds, capable of interacting with the cytoplasmic membrane, causing its irreversible 
damage (Donsì et al., 2014). 
 
Previous work for bacteria and fungi have demonstrated that restructuring essential oils into 
positively charged nanoemulsions can enhance antimicrobial efficacy by 1-2 log (Salvia-
Trujillo et al. 2014). In this study, we hypothesize that incorporation of a strongly oxidizing 
essential oil (carvacrol) into a nanoemulsion with cationic surfactant (CTAB) will enhance 
delivery of a nanoemulsion to negatively charged norovirus particles. The 0.5 and 1.0% (v/v) 
concentration of carvacrol nanoemulsions were exam as a model microorganism of desired 
droplet size and charge.  
 
The hypothesis of development of an efficacious carvacrol nanoemulsion (>4 log10 
reduction of viral titer) that can be incorporated into foods or used on food contact surfaces 
is of significant interest to the food industry as well as for public health. 
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3.3. Materials and Methods 
3.3.1. Bacterial Hosts and Cell Lines 
Bacteriophage MS2 was kindly provided as a gift by L-A. Jaykus (North Carolina 
State University, Raleigh, NC) and its host Escherichia coli strain (ATCC 15597), 
were purchased from ATCC (Manassas, VA).  
3.3.2. Escherichia Coli Preparation 
Incubated Escherichia coli was kept at -80°C in a mixture of TSB containing 0.1% 
thiamine and 0.2% glucose and 50%v/v of glycerol as frozen stock. Before use, 
Escherichia coli was streaked in appropriate selective media (5ml TSB containing 0.1% 
thiamine and 0.2% glucose) with cultured tubes at 37°C in an atmosphere containing 
5% CO2 for 18 h. 
3.3.3. Bacteriophage MS2 Plaque Assay 
Incubated Escherichia coli from frozen stock in 5ml TSB containing 0.1% thiamine 
and 0.2% glucose at 37°C in an atmosphere containing 5% CO2 for 18h. Adding 300ul 
of overnight Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1% 
thiamine and 0.2% glucose in a 100ml conical flask. Incubate the Escherichia coli at 
37 °C in an atmosphere containing 5% CO2 using an incubator shaker (100 rpm) for 2h 
until the optical density at 600 nm of 0.60. As a guideline, an OD600 of 0.6 corresponds 
to approximately 2.6 × 108 CFU/ml for cultures of Escherichia coli strains. Warmed 
1.0% TSA plates containing 0.1% thiamine and 0.2% glucose in 37°C for at least 1 
hour prior to plaque assay beginning. Melted and tempered desired tubes of 9ml-0.5% 
TSA containing 0.1%thiamine and 0.2% glucose in a 50°C water bath. MS2 stock (3.18 
× 1011 PFU/ml) was serially diluted in TSB containing 0.1% thiamine and 0.2% glucose, 
and 0.7 mL of diluted phage was mixed with 0.3 ml of 2-h Escherichia coli host. The 
1-ml host-MS2 combination was then added to 9ml of 0.5% TSA containing 0.1% 
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thiamine, 0.1% calcium chloride and 0.2% glucose, mixed and poured on 1% TSA 
containing 0.1% thiamine and 0.2% glucose bottom agar plates, and incubated at 37°C 
overnight. To obtain accurate quantitative analyses of plaque numbers, petri plates 
should have relatively diluted MS2 samples (25 to 250 PFU/plate). 
3.3.4. Propagation of Bacteriophage MS2 
Selected plate with complete lysis and flooded with 3ml TSB 0.1% thiamine and 0.2% 
glucose. Gently scraped off the top layer of MS2 plaques formation surface into sterile 
50ml tubes as over layer of complete lysis plaques suspensions. Bring volume to 40ml 
with TSB containing 0.1% thiamine and 0.2% glucose. Adding 0.2g of EDTA and 
0.026g of lysozyme to each tube and vortex for 10s. Incubated each tube at 37°C in an 
atmosphere containing 5% CO2 using an incubator shaker (100 rpm) for 2h. The over 
layer of complete lysis plaques suspensions were then centrifuged at 9280G for 10min. 
Adding supernatant in 0.22um sterilize filter and then aliquoted to 1ml storage 
cryogenic tubes. Storing at either 4°C for several weeks or -80°C for several years. 
Cryoprotectant (such as glycerol) is not necessary.  
3.3.5. Antiviral Effects of Nanoemulsion on MS2 
Incubated Escherichia coli from frozen stock in 5ml TSB containing 0.1% thiamine 
and 0.2% glucose at 37°C in an atmosphere containing 5% CO2 for 18h. Adding 300ul 
of overnight Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1% 
thiamine and 0.2% glucose in a 100ml conical flask. Incubate the Escherichia coli at 
37°C in an atmosphere containing 5% CO2 using an incubator shaker (100 rpm) for 2h 
until the optical density at 600 nm of 0.60. As a guideline, an OD600 of 0.6 corresponds 
to approximately 2.6 × 108CFU/ml for cultures of Escherichia coli strains. Gently 
thawed MS2 stock (8.71 × 1010PFU/ml) on ice, diluted in 1/100 (10ul MS2 in 990ul 
nuclease-free distilled water). Each concentration of sterile-dilute Nano-emulsion 
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(500ul) was mixed with an equal volume of MS2 (500ul) and incubated with gentle 
rotation for desired time (10-60 min) at room temperature. Sterile-dilute nano-emulsion 
was replaced with nuclease-free distilled water which also incubate with gentle rotation 
for desired time (10 to 60min) at room temperature used as the untreated controls. After 
incubation, treated MS2 and untreated control were neutralized in TSB containing 3% 
meat extract. MS2 plaque assays were performed using incubated 2-h Escherichia coli. 
MS2 treated with sterile-dilute nano-emulsion or water after neutralization with TSB 
containing 3% meat extract was serially diluted in TSB containing 0.1% thiamine and 
0.2% glucose, and 0.7 ml of diluted phage was mixed with 0.3 ml of 2-h Escherichia 
coli host. The 1-ml host-MS2 combination was then added to 9ml of 0.5% TSA 
containing 0.1% thiamine, 0.1% calcium chloride and 0.2% glucose, mixed and poured 
on 1% TSA 0.1% thiamine and 0.2% glucose bottom agar plates, and incubated at 37°C 
overnight before counting. 
3.3.6. Antibacterial Effects of Nanoemulsion on Escherichia coli 
Incubated Escherichia coli from frozen stock in 5ml TSB containing 0.1% thiamine 
and 0.2% glucose at 37°C in an atmosphere containing 5% CO2 for 18h. Adding 300ul 
of overnight Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1% 
thiamine and 0.2% glucose in a 100ml conical flask. Incubate the Escherichia coli at 
37 °C in an atmosphere containing 5% CO2 using an incubator shaker (100 rpm) for 2h 
until the optical density at 600 nm of 0.60. As a guideline, an OD600 of 0.6 corresponds 
to approximately 2.6 × 108 CFU/ml for cultures of Escherichia coli strains. A 0.5ml-
aliquot of incubated bacterial culture was mixed with 0.5ml of the carvacrol 
nanoemulsion and 9.0 ml of nuclease-free distilled water. To determine the inactivation 
kinetics, an aliquot was taken after 15, 30 and 60min of contact time. A control was 
performed with the same method, replacing the nanoemulsion by nuclease-free distilled 
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water. Minimum inhibitory concentration (MIC) were performed by using Escherichia 
coli treated with sterile-dilute nano-emulsion or water. Serially diluted treated and 
untreated Escherichia coli in TSB containing 0.1% thiamine and 0.2% glucose, and 0.1 
ml of diluted cultures were poured on 1% TSA 0.1% thiamine and 0.2% glucose bottom 
agar plates. And incubated at 37°C overnight before counting.  
3.3.7. Statistical analysis 
Each experiment was performed in triplicate and all values are reported as the mean ± 
standard deviation (SD) by Microsoft Excel. Results from the plaque assay of 
treatments and non-treatment controls were statistically assayed in duplicate plates and 
two replicate analyses were made of each nano-emulsion sample. 
3.4. Results 
The degree to which restructuring carvacrol into positively charged nanoemulsions was 
investigated in this work. The levels of 0.5% and 1.0% carvacrol were chosen for a number 
of reasons. Based on work presented in Chapter 2, 0.5 to 1.0% carvacrol produced stable 
nanoemulsions with the desired droplet size (from 112.3to 95.5 nm) and Zeta-potential 
(from+13 to +11 mV). Additionally, previous work (Gilling et al., 2014) demonstrated 
these concentrations exhibited antiviral activity (nearing 4 log reduction after 24h) on MNV 
using 0.5% purified carvacrol. Therefore, 0.5 to 1.0% of carvacrol nanoemulsions were 
made in this study. 
3.4.1. Effect of 0.5 and 0.83% Carvacrol Nanoemulsions Dissolved in PBS on MS2 
The 0.5 and 0.83% carvacrol nanoemulsions dissolved in PBS had no antiviral effect 
(Fig. 3). 2.5×107 and 2.7×107 viral titers of MS2 were observed across treatment groups 
(MS2 was treated with 0.5 and 0.83% carvacrol nanoemulsion) compared with 
untreated control (2.1×107) and neutralization control (2.1×105) by same treatment 
contact time (60min). Although treatment with PBS in different plaques population in 
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MS2, it was not significantly different from nuclease-free distilled water or PBS. 
 
 
Fig. 3. Effect of 0.5 and 0.83% carvacrol nanoemulsions dissolved in PBS on MS2. At 60 
min contact time, 0.5 and 0.83% carvacrol nanoemulsion dissolved in PBS shows no 
antiviral efficacy compared with non-treatment control.  
3.4.2. Effect of 0.5 and 1.0% Carvacrol Nanoemulsions Dissolved in Nuclease-Free 
Distilled Water on MS2  
The results of antiviral effect are shown in Fig. 4. The antiviral efficacy of MS2 was 
determined by comparison with the plaque reductions at the same treatment contact 
time (60min) at room temperature. 8.8×106 and 1.4×106 viral titers of MS2 were 
observed when MS2 treated with 0.5% and 1.0% carvacrol nanoemulsions 7.1×106 viral 
titers were observed at untreated control. The antiviral effect of 0.5% carvacrol 
nanoemulsion showed no antiviral activity than non-treatment control. However, 
carvacrol was examined at concentrations of 1.0%, 0.7 log reductions in comparison 
with the non-treatment controls at 60min contact time. In order to validate the 
experimental treatment protocol, 1.0% bleach showed complete inactivation, as 
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previously reported (Whitehead et al., 2010). Therefore, 0.5 and 1.0% carvacrol 
nanoemulsions dissolved in water showed lower efficacy on MS2 than carvacrol alone.  
 
 
Fig. 4. Effect of 0.5 and 1.0% carvacrol nanoemulsions dissolved in nuclease-free distilled 
water on MS2. 0.5 and 1.0% carvacrol nanoemulsions dissolved in nuclease-free distilled 
water showed lower antiviral efficacy. The antiviral effect of 0.5% carvacrol 
nanoemulsion showed no antiviral activity than non-treatment control. However, 
carvacrol was examined at concentrations of 1.0%, a 0.7 log10 reductions in comparison 
with the non-treatment controls at 60 min contact time.  
3.4.3. Effect of 1.0% Carvacrol Nanoemulsion Dissolved in Nuclease-Free Distilled 
Water on Escherichia Coli in Different Contact Time 
In order to see if carvacrol nanoemulsions required a lipid membrane for efficacy, the 
antimicrobial effects of a 1.0% carvacrol nanoemulsion optimized against Escherichia 
coli showed in Fig. 5. The treatment on 1.0% carvacrol nanoemulsion dissolved 
nuclease-free distilled water shows low antibacterial efficacy. 2×107 CFU/ml bacterial 
titers were observed at non-treatment control and 9×106, 2×107 and 1.6×107 CFU/ml 
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were observed after contacted with 1% carvacrol nanoemulsion at 15, 30 and 60min. 
The results indicated that the 1.0% carvacrol nanoemulsions at 15, 30 and 60 min 
contact time achieved 0.35, -0.04 and 0.03 log10 bacteria colony reduction compare 
with non-treatment control. In order to present the experiment protocol, 1.0% bleach in 
30 min contact time exams completely inactive antibacterial effect. In addition, no 
significant difference was observed between MS2 bacterial phage and Escherichia coli 
microorganism reduction on 1.0% nanoemulsion dissolved in nuclease-free distilled 
water, 
 
Fig. 5. Effect of 1.0% carvacrol nanoemulsion dissolved in water on Escherichia Coli. In 
different contact time. 1.0% carvacrol nanoemulsion dissolved in nuclease-free distilled in 
water shows low antibacterial efficacy. At 15, 30 and 60 min contact time, 1.0% carvacrol 
nanoemulsion achieved 0.35, -0.04 and 0.03 log10 bacteria colony reduction compare with 
non-treatment control. 
 
3.4.4. Effect of 1.0 and 10% Carvacrol Emulsion Dissolved in Water on Escherichia 
Coli in 60min Contact Time  
The antimicrobial effects of 1.0% carvacrol optimized against Escherichia coli showed 
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in Fig. 6. The results indicated that the 1.0% carvacrol at 60 min contact time has no 
bacteria colony reduction. 1.9 ×107 CFU/ml was observed after contacted with 1% 
carvacrol compare with non-treatment control (1.7×107 CFU/ml). Additionally, the both 
results of 1% carvacrol nanoemulsion and 1% carvacrol showed the similar effect (no 
antibacterial reduction) on Escherichia coli at 60 min contact time. However, in 10% 
carvacrol treatment at same contact time, a 7.2 log10 reduction was achieved. Therefore, 
the higher concentration (10%) of carvacrol itself has higher antibacterial effect than 
lower concentration (1.0%).  
 
Fig. 6. Effect of 1.0 and 10% carvacrol emulsion dissolved in water on Escherichia Coli. In 
60min contact time. 1.0% carvacrol essential oil dissolved in nuclease-free distilled water 
shows no antibacterial efficacy compared to non-treatment control However, 7.2 log10 
reductions were observed at 10% carvacrol in comparison with the non-treatment controls at 
60 min contact time.  
3.5. Discussion 
In this work, restructuring carvacrol in positively charged nanoemulsions did not enhance 
antiviral efficacy against bacteriophage MS2. The hypothesis that positively charged 
nanoemulsions would enhance delivery of carvacrol to the hydrophobic contacts that hold 
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the negatively charged viral protein capsid together was found not true. This suggests that 
nanoemulsions made using the low energy method may require the target microorganism 
to have a lipid membrane to enhance antimicrobial efficacy. 
 
Therefore, in this study, we applied different concentrations of carvacrol nanoemulsions 
dissolved in different aqueous phase (nuclease-free distilled water) to exam antimicrobial 
efficacy on MS2 and Escherichia coli. In different concentration (0.5 and 1.0%) of 
carvacrol nanoemulsion dissolved in nuclease-free distilled water showed -0.09 and 0.7 
log10 antiviral reduction; these two concentrations of nanoemulsion did not show 
significant reduction compared to the non-treatment control.  
 
Various mechanisms, such as applied low concentration (0.5%) of carvacrol could decrease 
the antiviral efficacy. The results showed that 1% carvacrol nanoemulsion dissolved in 
water which has higher viral reduction (0.7 log10 reduction) than 0.5% nanoemulsion (-0.09 
log reduction). Therefore, we could increase the higher ratio of carvacrol that may increase 
the antiviral efficacy. For example, we can raise carvacrol from 0.5 or 1.0% to 5% that may 
increase antiviral efficacy, and could be grounds for future work. 
 
However, a previous study (Terjung et al., 2012) proved that essential oils prefer to stay at 
oil-in-water interfaces, therefore, the reduction of the specific interfacial area of emulsions 
by increasing the essential oil droplet size caused the increase of essential oil concentration 
in aqueous phase. When the concentration of carvacrol nanoemulsion is increased, the 
nanoemulsion droplet size may also increase—destabilizing the nanoemulsion. In addition, 
when raising carvacrol from 0.5 or 1.0% to 10%, we may reduce the concentration of 
surfactant (Tween 80) that may increase carvacrol nanoemulsion droplet.  
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To optimize carvacrol nanoemulsion droplet size, adding an appropriate ratio between oil 
and surfactant phase can helps formation of small droplets. In the field of nutraceutical 
delivery systems, nanoemulsion of appropriate droplet size is between 10 nm and 200 nm 
(Solans et al., 2005; Sagalowicz et al., 2010) because they can enhance the cell absorption 
by enabling passive mechanisms by pass through the cellular membrane due to their sub-
cellular size (Donsì et al., 2012). Moreover, increasing the surfactant concentration help 
formulate the smaller droplets size because surfactant can lowers the interfacial tension at 
the oil-in-water interface (Chuesiang et al., 2019). Therefore, design criteria for the choice 
of the higher concentration in the formulation of the carvacrol nanoemulsion-based delivery 
system should be took into account on targeting bacteriophage MS2.  
 
Since significant antimicrobial properties have been reported for carvacrol it has potential 
to be used as an antimicrobial agent in the food industry (Mazarei et al., 2019). In this study, 
antibacterial effects of 1.0% carvacrol nanoemulsion showed slight effect (0.35 log10 
reduction) against Escherichia coli at 15 min contact time while, 1% carvacrol 
nanoemulsion showed no antibacterial effect at 30 and 60 min contact time on Escherichia 
coli. 
 
As previous described in section 3, various mechanisms, such as applied low concentration 
of carvacrol, could decrease the antibacterial efficacy. The higher ratio of carvacrol 
essential oil may increase antibacterial efficacy. For example, raising carvacrol from 1.0% 
to 10% may increase antiviral efficacy. However, increasing the concentration of carvacrol 
nanoemulsion, can increase droplet size on nanoemulsion. The antimicrobial activity 
against Escherichia coli resulted to be significantly dependent on emulsion droplet size, 
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and not to be affected by emulsion formulation, in agreement with the behavior observed 
for the plant-base emulsions, in particular with nanoemulsions of sub-cellular mean droplet 
size (<200 nm) caused a higher inactivation (Donsì et al., 2012). Therefore, these results 
demonstrate that the 1% carvacrol nanoemulsion has low antibacterial efficacy in 15, 30 
and 60 min contact time. 
 
3.6. Conclusion 
In conclusion, in this study, we applied different concentration of carvacrol nanoemulsion to 
evaluate whether the desire of droplet size and charged can enhance delivery to negatively 
charged viral capsid. The results showed low antimicrobial activities regardless of all 
concentration. However, 10% carvacrol showed strong antibacterial affect (7 log10 reduction), 
the results proved that carvacrol is an antimicrobial agent as reports from recent studies. In 
future work, we can raise carvacrol nanoemulsion concentration to 5%, that may increase 
antimicrobial compound for interacting with microorganism.    
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CHAPTER 4  
CARVACROL EMULSION ANTIMICROBIC EFFICACY ON BACTERIOPHAGE 
MS2 AND ESCHERICHIA ECOLI 
 
4.1. Abstract 
Carvacrol is considered to improve food safety and the health of customers, and have been 
registered by U.S. Food and Drug Administration and recognized as safe component. Carvacrol 
is the antimicrobial monoterpene phenolic compounds which contains with lipophilic and 
volatile secondary metabolites that can thus interact with the cell physicochemical properties. 
In this study, the antimicrobial efficacy of carvacrol oil-in-water emulsions of concentrations 
of 0.1, 0.5, 1.0, and 10% were examined on bacteriophage MS2; 1.0 and 10% carvacrol  were 
also examined on Escherichia coli. In addition, carvacrol oil-in-water emulsion stabilized by a 
nonionic surfactant (Tween 80) and cationic surfactant (CTAB) or in combination with anionic 
surfactant (sodium dodecyl sulfate) in inactivation of MS2 was also investigated. In antiviral 
efficacy, carvacrol at 0.1, 0.5, 1.0 and 10% have no reduction on bacteriophage MS2 at 60min 
contact time. In antibacterial efficacy, the 1.0% concentration showed no bacteria colony 
reduction on E. coli while 10% carvacrol showed 7.2 log10 reduction at 60min contact time. At 
ionic surfactant on antiviral efficacy test, 0.1% sodium dodecyl sulfate (SDS) showed no 
reduction while 0.2% CTAB and 0.25% SDS showed slight antiviral reduction (0.6 and 0.55 
log reduction) on the phage. Moreover, a 2.5 log10 reduction was observed at 0.5% SDS on 
MS2. Due to there is no antiviral reduction when we applied carvacrol along on MS2, thus we 
added an appropriate amount of cationic or anionic surfactant to investigate whether additional 
ionic surfactant can improve antiviral efficacy. In combination 1% carvacrol with surfactant 
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study, incubated aliquot MS2 and cationic carvacrol emulsion contained (1% carvacrol plus 
0.5% Tween 80 and 0.2% CTAB) at 60min, a 2 log10 reductions was observed on MS2. In 
anionic emulsion (contained 1% carvacrol plus 0.25 or 0.5% SDS), mixed separately 0.25 or 
0.5% SDS with MS2 for 30 min and 60 min. At both 0.25 and 0.5% SDS, the ~4.6 log10 
reduction were observed at two different contact time (30 and 60min). In this study, both 
cationic and anionic carvacrol emulsion can improve the antiviral efficacy, the results represent 
a step forward in improving food safety and reduce viral plaques colony by using carvacrol oil-
in-water emulsion combining surfactant. 
4.2. Introduction  
Carvacrol, a monoterpene phenol, has emerged as a natural antimicrobial due to its wide 
spectrum activity against food spoilage and pathogenic fungi, yeast and bacteria (Nostro et al., 
2012). Carvacrol is the primary component of oregano essential oil and has been identified as 
a natural economical food preservative (Lu et al., 2010; Obaidat et al., 2009). It has recently 
been reported that carvacrol could effectively reduce the infectivity of murine norovirus (MNV) 
(Gilling et al., 2014), a HuNoVs surrogate, and rotavirus (Pilau et al.,2011). The area of 
particular interest is their potential to inhibit some of the most serious foodborne pathogens, 
such as Escherichia coli (Božik et al. 2018) . However, the effectiveness of carvacrol oil-in-
water emulsion plus ionic surfactant against bacteriophage MS2 and Escherichia coli, as well 
as its efficacy in food applications has yet to be explored. 
 
Since the water solubility of carvacrol is as low as 0.11-0.83 g/l at 25°C (Chen et al., 2014), it 
is difficult to directly inactive MS2 by only using carvacrol. Therefore, we applied surfactant 
that provide information about the solute-solvent interactions. The surface-active properties 
describe the interaction of surfactant molecules between two phases, a desired amount of 
surfactant can adsorb with their molecular arrangement and reduce surface tension (Danov et 
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al., 2012), that improve the carvacrol solubility in solution. 
 
In oil-in-water emulsion system, the solubility of essential oil can be altered by using non-ionic 
surfactants (Tween 80). The polysorbate family of surfactants (included Tween 80), can be used 
by mixing water, the surfactant, and essential oil using a vortex mixer (Chen et al., 2014). 
Additionally, a study (Kumar et al., 2018) suggested that non-ionic surfactant also help forms 
a stable oil-in-water emulsion. Therefore, adding an appropriate amount of Tween80 for 
suitability in carvacrol emulsion system could be took in account in this study. 
 
Addition of a cationic surfactant to emulsions has been shown to further enhance antimicrobial 
activity (Ziani et al., 2011). The mechanism of antibacterial effect of essential oil is mainly 
based on the hydrophobicity of their constituent molecules. In the case of virus, the positively 
charged compounds can adsorb on viral capsid by also electrostatic interaction which inhibit 
viral adsorption on host cells. However, the microbial activities of cationic compounds have 
mainly been focused on pathogenic bacterial but they were less studied on viruses (Pan et al., 
2006). 
 
SDS, as a surfactant compound (Singer et al.,1993), makes the liquid spread more easily and 
can lower the interfacial tension between two liquid (Li et al., 2013), which facilitates the 
organic compound to penetrate the cell membrane and accumulate. Previous research 
suggested SDS is able to cause significant damages to viral structures of both enveloped and 
nonenveloped viruses; the result on combinations of SDS with chlorinated water improved 
inactivation of HuNoV surrogates on fresh vegetables and Fruits (Predmore et al., 2011). 
Another study (Zhou et al., 2017) also presents that the treatment of washing with levulinic 
acid plus SDS was able to reduce MNV-1 and MS2 on strawberry (Aydin et al., 2013). 
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In this study, we hypothesize that incorporation of nonionic (Tween 80) plus cationic (CTAB), 
or anionic (SDS) surfactant will enhance the efficacy of a strongly oxidizing essential oil active 
compound (carvacrol) on bacteriophage MS2 and Escherichia coli. The development of an 
efficacious natural disinfectant (>4 log10 reduction of viral titer) that can be incorporated into 
foods or used on food contact surfaces is of significant interest to the food industry as well as 
for public health. 
4.3. Materials and Methods 
4.3.1. Bacterial Hosts, and Cell Lines 
Bacteriophage MS2 was kindly provided as a gift by L-A. Jaykus (North Carolina State 
University, Raleigh, NC) and its host Escherichia coli strain (ATCC 15597), were purchased 
from ATCC (Manassas, VA). 
4.3.2. Escherichia Coli Preparation 
Incubated Escherichia coli was kept at -80°C in a mixture of TSB containing 0.1% thiamine 
and 0.2% glucose and 50%v/v of glycerol as frozen stock. Before use, Escherichia coli was 
streaked in appropriate selective media (5ml TSB containing 0.1% thiamine and 0.2% glucose) 
with cultured tubes at 37°C in an atmosphere containing 5% CO2 for 18 h. 
4.3.3. Bacteriophage MS2 Plaque Assay 
Incubated Escherichia coli from frozen stock in 5mL TSB containing 0.1% thiamine and 0.2% 
glucose at 37°C in an atmosphere containing 5% CO2 for 18h. Adding 300ul of overnight 
Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1% thiamine and 0.2% 
glucose in a 100ml conical flask. Incubate the Escherichia coli at 37 °C in an atmosphere 
containing 5% CO2 using an incubator shaker (100 rpm) for 2h until the optical density at 600 
nm of 0.60. As a guideline, an OD600 of 0.6 corresponds to approximately 2.6 × 108 CFU/ml 
for cultures of Escherichia coli strains. Warmed 1.0% TSA plates containing 0.1% thiamine 
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and 0.2% glucose in 37 °C for at least 1 hour prior to plaque assay beginning. Melted and 
tempered desired tubes of 9ml-0.5% TSA containing 0.1%thiamine and 0.2% glucose in a 50°C 
water bath. MS2 stock (3.18 × 1011 PFU/ml) was serially diluted in TSB containing 0.1% 
thiamine and 0.2% glucose, and 0.7 mL of diluted phage was mixed with 0.3 mL of 2-h 
Escherichia coli host. The 1-ml host-MS2 combination was then added to 9mL of 0.5% TSA 
containing 0.1% thiamine, 0.1% calcium chloride and 0.2% glucose, mixed and poured on 1% 
TSA containing 0.1% thiamine and 0.2% glucose bottom agar plates, and incubated at 37°C 
overnight. To obtain accurate quantitative analyses of plaque numbers, petri plates should have 
relatively diluted MS2 samples (25 to 250 PFU/plate).  
4.3.4. Propagation of Bacteriophage MS2 
Selected plate with complete lysis and flooded with 3mL TSB 0.1% thiamine and 0.2% 
glucose. Gently scraped off the top layer of MS2 plaques formation surface into sterile 50ml 
tubes as over layer of complete lysis plaques suspensions. Bring volume to 40ml with TSB 
containing 0.1% thiamine and 0.2% glucose. Adding 0.2g of EDTA and 0.026g of lysozyme 
to each tube and vortex for 10s. Incubated each tube at 37°C in an atmosphere containing 5% 
CO2 using an incubator shaker (100 rpm) for 2h. The over layer of complete lysis plaques 
suspensions were then centrifuged at 9280G for 10 min. Adding supernatant in 0.22um sterilize 
filter and then aliquoted to 1mL storage cryogenic tubes. Storing at either 4°C for several weeks 
or -80°C for several years. Cryoprotectant (such as glycerol) is not necessary.  
4.3.5. Carvacrol Emulsion Preparation. 
Purified carvacrol (>98%) was purchased from Sigma-Aldrich (St. Louis, MO), 
Polyoxyethylene-80 (Tween 80) and Hexadecyltrimethylammonium bromide (CTAB) was 
purchased from (Markham, ON), were added with nuclease-free distilled water to form 
emulsion’s aqueous phase. Sodium dodecyl sulfate (SDS) was purchased from Sigma-Aldrich 
(St. Louis, MO), was added with nuclease-free distilled water to form emulsion’s aqueous 
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phase. Initially, few different amounts of purified carvacrol were mix with nuclease-free 
distilled water to form different concentration (0.1, 0.5, 1.0 and 10% v/v) of carvacrol 
emulsion. Nuclease-free distilled water (Thermo Fisher, Waltham, MA) was added with 0.2% 
of cationic surfactant (CTAB) and 0.5% Tween 80 for 1 min by using a vortex at room 
temperature to form an aqueous phase. A 1.0% carvacrol was then added at aqueous phase then 
all components were mixed for 1 min at 25 °C to make a cationic antimicrobial emulsion. In 
combining different surfactant with purified carvacrol to form emulsion, a 0.1, 0.25 and 0.5% 
(v/v) concentration of SDS were separately added with nuclease-free distilled water for 1 min 
by using a vortex at room temperature to form an aqueous phase. A 1.0% (v/v) carvacrol was 
then separately added to aqueous phase (with different concentration of SDS) then all 
components were mixed for 1 min at 25 °C to make an antimicrobial emulsion. 
4.3.6. Antiviral Effects of Carvacrol Emulsion on MS2. 
Incubated Escherichia coli from frozen stock in 5ml TSB containing 0.1% thiamine and 0.2% 
glucose at 37°C in an atmosphere containing 5% CO2 for 18 h. Adding 300ul of overnight 
Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1% thiamine and 0.2% 
glucose in a 100ml conical flask. Incubate the Escherichia coli at 37 °C in an atmosphere 
containing 5% CO2 using an incubator shaker (100 rpm) for 2h until the optical density at 600 
nm of 0.60. As a guideline, an OD600 of 0.6 corresponds to approximately 2.6 × 108CFU/mL 
for cultures of Escherichia coli strains. Gently thawed MS2 stock (8.71 × 1010 PFU/ml) on ice, 
diluted in 1/100 (10ul MS2 in 990ul sterile nuclease-free distilled water). First, 500ul of 0.1, 
0.5, 1.0 and 10% concentration of carvacrol emulsion were separately mixed with an equal 
volume of MS2 (500ul) and incubated with gentle rotation for desired time (60 min) at room 
temperature. In cationic antimicrobial, 500ul emulsion (contained 1.0% carvacrol, 0.2% CTAB 
and 0.5% Tween 80) was mixed with an equal volume of MS2 (500ul) and incubated with 
gentle rotation for desired time (60 min) at room temperature. Another emulsion was also tested 
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on suspension assay, 500ul of 1.0% carvacrol emulsion contained with a different 
concentration (0.1, 0.25 and 2.5% of SDS) was mixed with an equal volume of MS2 (500ul) 
and incubated with gentle rotation for two different desired time (30 and 60min) at room 
temperature. Antimicrobial carvacrol emulsion were replaced with sterile nuclease-free 
distilled water which also incubate with gentle rotation for desired time (30 and 60 min) at 
room temperature used as the untreated controls. After incubation, treated MS2 and untreated 
control were neutralized in TSB containing 3% meat extract. MS2 plaque assays were 
performed using incubated 2-h Escherichia coli. MS2 treated with 1.0% carvacrol emulsion or 
water after neutralization with TSB containing 3% meat extract was serially diluted in TSB 
containing 0.1%thiamine and 0.2% glucose, and 0.7 ml of diluted phage was mixed with 0.3 
ml of 2-h Escherichia coli host. The 1-ml host-MS2 combination was then added to 9ml of 
0.5% TSA containing 0.1% thiamine, 0.1% calcium chloride and 0.2% glucose, mixed and 
poured on 1% TSA 0.1% thiamine and 0.2% glucose bottom agar plates, and incubated at 37°C 
overnight before counting. 
4.3.7. Antibacterial Effects of Carvacrol Emulsion on Escherichia Coli. 
Incubated Escherichia coli from frozen stock in 5ml TSB containing 0.1% thiamine and 0.2% 
glucose at 37°C in an atmosphere containing 5% CO2 for 18 h. Adding 300ul of overnight 
Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1% thiamine and 0.2% 
glucose in a 100ml conical flask. Incubate the Escherichia coli at 37 °C in an atmosphere 
containing 5% CO2 using an incubator shaker (100 rpm) for 2h until the optical density at 600 
nm of 0.60. As a guideline, an OD600 of 0.6 corresponds to approximately 2.6 × 108CFU/mL 
for cultures of Escherichia coli strains. A 500ul-aliquot of incubated bacterial culture was 
mixed with 500ul of different concentration (1.0 and 10%) of carvacrol emulsion and 9.0 mL 
of sterile nuclease-free distilled water. To determine the inactivation kinetics, an aliquot was 
taken after 15, 30 and 60 min of contact time. A control was performed with the same method, 
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replacing the carvacrol emulsion by sterile nuclease-free distilled water. Minimum inhibitory 
concentration (MIC) were performed by using Escherichia coli treated with carvacrol emulsion 
or water. Serially diluted treated and untreated Escherichia coli in TSB containing 0.1% 
thiamine and 0.2% glucose, and 0.1 ml of diluted cultures were poured on 1% TSA 0.1% 
thiamine and 0.2% glucose bottom agar plates. And incubated at 37°C overnight before 
counting.  
4.3.8. Statistical Analysis. 
Each experiment was performed in triplicate and all values are reported as the mean ± standard 
deviation (SD) by Microsoft Excel. Results from the plaque assay of treatments and non-
treatment controls were statistically assayed in duplicate plates and two replicate analyses were 
made of each nano-emulsion sample. 
4.4. Results 
4.4.1. Carvacrol and Its Surfactants Antiviral Effect on MS2   
Low concentration (0.1, 0.5 and 1.0%) of carvacrol emulsion show low inactivation effect 
(<0.05 log reduction) on MS2 (Fig. 7.); although treatment with increasing the concentration 
on carvacrol to 10%, the results still showed no antiviral effect on the phage. At 0.2% CTAB 
treatment, a slight reduction (0.6 log) on bacteriophage MS2 showed as viral titers in Although, 
in 0.1% SDS showed no inactivation effect on bacteriophage MS2, a 0.55 and 2.5 log10 
reduction were observed when treated with 0.25 and 0.5% SDS at same treatment contact time 
showed as viral titers in Fig. 8.  
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Fig. 7. Carvacrol antiviral effect on bacteriophage MS2. Effect of 0.1, 0.5,1.0 and 10% 
carvacrol against bacteriophage MS2 at 60 min treatment contact time.  
 
 
Fig. 8. Cationic and anionic surfactant antiviral effect on bacteriophage MS2. 
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4.4.2. Cationic and Anionic Carvacrol Emulsion Antiviral Effect on MS2 
The results of antiviral effect are shown in Fig. 9. The antiviral efficacy of bacteriophage MS2 
was determined by comparison with the viral reductions at 60 min treatment contact time at 
room temperature. 2.7×105 viral titers were observed at cationic carvacrol nanoemulsion 
(contained 1% carvacrol 0.5% Tween 80 plus 0.2% CTAB) compared with non-treatment 
control (1.5×107 viral titers). 2.3×101 and 1.9×101 viral titers of MS2 were observed when MS2 
treated with anionic carvacrol emulsion (contained 1% carvacrol plus 0.25 or 0.5% SDS). The 
antiviral effect of cationic carvacrol emulsion (contained 1% carvacrol, 0.2% CTAB and 0.5% 
Tween 80) achieved 2 log10 reduction on MS2 compared to non-treatment control. When 
applied anionic carvacrol emulsion (contained 1% carvacrol and either 0.25 or 0.5% SDS), 
both were achieved 5.3 log10 reductions on MS2.  
 
Fig. 9. Cationic and anionic carvacrol emulsion antiviral effect on MS2 at 60 min contact 
time. Cationic carvacrol emulsion (contained 1% carvacrol, 0.2% CTAB and 0.5% Tween 
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80) and anionic carvacrol emulsion (contained 1% carvacrol and 0.25% or 0.5% SDS) 
antiviral effect on MS2. 
 
4.4.3. Anionic Carvacrol Emulsion Antiviral Effect on MS2 at 30 min Contact Time  
The results of antiviral effect are shown in Fig. 10.6×101 and 1×102 viral titers of MS2 were 
observed when MS2 treated with anionic carvacrol emulsion (contained 1% carvacrol plus 0.25 
and 0.5% SDS) and 4.6×106 viral titers were observed at untreated control. The antiviral 
efficacy of MS2 was determined by comparison with the log10 reductions at the 30 min 
treatment contact time at room temperature. In 30 min of treatment contact time, the antiviral 
effect of anionic carvacrol emulsion contained different concentration (0.25 and 0.5%) of SDS. 
A 4.8 log reduction was overserved in MS2 with 1% carvacrol emulsion (contained 0.25%SDS) 
and a 4.6 log reduction was overserved in MS2 with 1% carvacrol emulsion (contained 
0.5%SDS). Therefore, anionic carvacrol emulsion contains with different concentration of 
SDS, all have strong antiviral efficacy on the phage at 30 min contact time showed in Fig. 10. 
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Fig. 10. Anionic carvacrol emulsion antiviral effect on MS2 at 30 min contact time. 
Anionic carvacrol emulsion (contained 1% carvacrol, 0.25 or 0.5% SDS) antiviral effect 
on MS2at 30 min contact time. 
4.4.4. Effect Of 1.0 And 10% Carvacrol Emulsion Dissolving in Water on Escherichia 
Coli in 60min Contact Time. 
The antimicrobial effects of 1.0% carvacrol optimized against Escherichia coli showed in 
Fig.6. The results indicated that the 1.0% carvacrol at 60 min contact time has no bacteria 
colony reduction (1.9 ×107 CFU/ml bacterial titers compare with non-treatment control 
1.7×107 CFU/ml). However, in 10% carvacrol treatment at same contact time, a 7.2 log10 
reduction was achieved. Therefore, the higher concentration (10%) of carvacrol essential has 
higher antibacterial effect than lower concentration (1%).  
4.5. Discussion 
We hypothesized carvacrol oil-in-water emulsion could improve antiviral efficacy, however 
0.1, 0.5, 1.0 and 10% carvacrol emulsion dissolved in water shows no antiviral efficacy. There 
is no viral reduction compare occurred following 0.1, 1.0 and 10% treated carvacrol than non-
treatment control at 60 min treatment contact time. In addition, in antimicrobial efficacy, the 
results indicated that 1.0% carvacrol emulsion at 60 min contact time has no bacteria colony 
reduction. However, in 10% carvacrol emulsion treatment at same contact time (60 min), a 7.2 
log reduction was achieved. It has been reported that hydrophobicity of carvacrol could be an 
advantage for inducing antibacterial properties. It is well known that lipophilic compounds 
possess a high affinity for cell membranes and their insertions induce changes in membrane 
physicochemical properties. The interactions of antimicrobial compounds and cell membranes 
are considered to affect both the lipid ordering and the bilayer stability, resulting in a membrane 
integrity decrease and potential depolarization (Arfa et al., 2006). In addition, a study by (Ultee 
et al., 1998) presented the carvacrol concentration increases, more of the compound is expected 
to dissolve in the membrane and more damage of the membranes appears. 
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Since the water solubility of carvacrol is low, we investigated the ability of three representative 
surfactants (Tween 80) to enhance solubility to enhance carvacrol antimicrobial efficacy. The 
solubility of essential oil can be altered by using a neutral surfactant Tween 80 (Chen et al. 
2014) and addition of a cationic surfactant to emulsions can further enhances antimicrobial 
activity (Ziani et al. 2011) due to the positive charge of CTAB. A 0.6 log reduction was 
achieved when only apply 0.2% CTAB dissolved in nuclease-free distilled water, the results 
showed the cationic surfactant has slight antiviral effect on bacteriophage MS2.   
 
In 1% carvacrol emulsion (contained 0.5% Tween plus 0.2% CTAB), Tween 80 helps oil-in-
water emulsion form smaller droplet size, the surfactant is favored by inequality in the 
hydrocarbon chain length (Wang et al. 2009). The unequal surfactant chain length is expected 
to lead to a more disarranged surfactant/oil interface, hence, producing a region of enhanced 
oil mixing (Eastoe et al. 2003). In order to find an antiviral effect on bacteriophage MS2, the 
positively charged compounds, including CTAB may enhance emulsions antiviral activity (Ly-
Chatain et al., 2013). Additionally, the positively charged compounds can adsorb on viral 
capsid by also electrostatic interaction which inhibit viral adsorption on host cells (Pan et al., 
2006). At pH acid, phages have a neutral or positive charge leading to a reduction the 
absorption of cationic compounds on phage. A lower cell viability have been observed when 
the cell surface charge change from negative to positive (Ly-Chatain et al., 2013). In this study, 
when we applied 0.2% CTAB surfactant along against bacteriophage MS2, a 0.6 log10 
reduction was achieved. Therefore, we made a carvacrol emulsion (1.0% carvacrol plus 0.5% 
Tween 80 and 0.2% CTAB), a 2 log10 reduction on MS2 was observed at 60 min contact time. 
Although results showed a moderate antiviral efficacy, carvacrol emulsion (1.0% carvacrol 
plus 0.5% Tween 80 and 0.2% CTAB) proved that the additional of CTAB cause further 
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antiviral effect (compared with 1% carvacrol along) on MS2. 
 
In addition, we also applied 1.0% carvacrol emulsion plus a different concentration (0.25 and 
0.5%) of SDS to exam the antiviral efficacy on bacteriophage MS2. Anionic surfactants (SDS), 
which can reduce the surface tension of water by adsorbing at the liquid-gas or liquid-liquid 
interface and thus can potentially enhance the removal of viruses from fresh produce. Another 
alternative is that the surfactants are able to directly denature the virus, resulting in inactivation 
during sanitization (Predmore et al., 2011).  
 
In the present study, we tested the different concentration (0.1, 0.25 and 0.5%) of SDS to exam 
the anionic surfactant antiviral efficacy. Although 0.1% SDS showed no antiviral reduction, 
0.5 and 2.5 log10 reduction were observed when applied 0.25 and 0.5% SDS on bacteriophage 
MS2. Therefore, we tested 1% carvacrol emulsion in combination with 0.25 and 0.5% 
concentration of SDS surfactants at two different contact times (30 and 60 min). In all cases, 
two different concentration of SDS show significant antiviral efficacy at two different contact 
time (30 and 60min). These results presented at 0.25 an 0.5% SDS concentration in treatment 
with 30 and 60 min contact time, treated phage were all observed a >4.6 log viral reduction on 
MS2. This is due to the fact that the viricidal activity of surfactants for sexually transmitted 
mechanism in viral capsid (Howett et al., 1999); the capsid protein of norovirus surrogate 
became aggregated after incubation with SDS and that the structure of viral capsid was severely 
altered (Predmore et al., 2011).  
 
4.6. Conclusion 
Taken together, in anionic carvacrol nanoemulsions antiviral activities, the results suggest that 
SDS as well as other surfactants can be useful in the inactivation of both enveloped and 
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nonenveloped. Viruses. In future study, we can apply lower concentration of carvacrol to 
combine with SDS. Since 1% carvacrol combine with 0.5% Tween 80 plus 0.2% CTAB or 1% 
carvacrol combine with 0.2 or 0.5% SDS can show the strong antiviral efficacy. To lower down 
the 1% carvacrol emulsion to 0.5% or 0.1% may still show the reduction on the phage.  
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